Sp1	B-protein
is	O
a	O
critical	O
factor	O
for	O
the	O
monocytic	O
specific	O
expression	O
of	O
human	B-protein
CD14	I-protein
.	O

CD14	B-protein
is	O
a	O
membrane	B-protein
glycoprotein	I-protein
expressed	O
specifically	O
on	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
,	O
and	O
its	O
expression	O
is	O
markedly	O
increased	O
during	O
the	O
process	O
of	O
monocyte	B-cell_type
differentiation	O
.	O

In	O
order	O
to	O
study	O
CD14	B-DNA
gene	I-DNA
regulation	O
,	O
the	O
human	B-DNA
CD14	I-DNA
gene	I-DNA
was	O
cloned	O
from	O
a	O
partial	O
EcoRI	B-DNA
digested	I-DNA
chromosome	I-DNA
5	I-DNA
library	I-DNA
.	O

A	O
5.5-kilobase	B-DNA
genomic	I-DNA
clone	I-DNA
contained	O
the	O
full-length	O
CD14	B-DNA
coding	I-DNA
sequence	I-DNA
and	O
4.2	B-DNA
kilobases	I-DNA
of	I-DNA
5'-upstream	I-DNA
sequence	I-DNA
.	O

One	O
major	B-DNA
and	I-DNA
one	I-DNA
minor	I-DNA
transcription	I-DNA
start	I-DNA
site	I-DNA
were	O
identified	O
101	B-DNA
and	I-DNA
130	I-DNA
base	I-DNA
pairs	I-DNA
(	I-DNA
bp	I-DNA
)	I-DNA
upstream	I-DNA
,	O
respectively	O
,	O
from	O
the	O
protein	B-DNA
translation	I-DNA
start	I-DNA
ATG	I-DNA
.	O

A	O
DNA	B-DNA
fragment	I-DNA
containing	O
128	B-DNA
bp	I-DNA
of	I-DNA
upstream	I-DNA
sequence	I-DNA
had	O
strong	O
,	O
monocyte-specific	O
promoter	O
activity	O
in	O
the	O
CD14	B-cell_line
positive	I-cell_line
monocytic	I-cell_line
cell	I-cell_line
line	I-cell_line
Mono	B-cell_line
Mac	I-cell_line
6	I-cell_line
as	O
compared	O
to	O
the	O
nonmonocytic	B-cell_line
cell	I-cell_line
lines	I-cell_line
HeLa	B-cell_line
and	O
REX	B-cell_line
.	O

Four	O
regions	O
in	O
this	O
DNA	B-DNA
fragment	I-DNA
interact	O
with	O
nuclear	B-protein
proteins	I-protein
isolated	O
from	O
monocytic	B-cell_type
cells	I-cell_type
.	O

The	O
Sp1	B-protein
transcription	B-protein
factor	I-protein
bound	O
to	O
three	O
different	O
regions	O
in	O
the	O
CD14	B-DNA
promoter	I-DNA
.	O

Mutation	O
of	O
the	O
major	B-DNA
Sp1	I-DNA
binding	I-DNA
site	I-DNA
(	O
-110	B-DNA
bp	I-DNA
)	O
decreased	O
tissue-specific	O
promoter	O
activity	O
,	O
and	O
these	O
results	O
,	O
together	O
with	O
transactivation	O
experiments	O
,	O
demonstrate	O
that	O
Sp1	B-protein
plays	O
a	O
critical	O
role	O
in	O
the	O
tissue-specific	O
expression	O
of	O
CD14	B-protein
in	O
monocytic	B-cell_type
cells	I-cell_type
.	O

CD14	B-protein
Sp1	B-protein
site	O
oligonucleotides	O
bound	O
preferentially	O
to	O
a	O
105-kDa	B-protein
Sp1	I-protein
species	I-protein
,	O
which	O
is	O
present	O
in	O
higher	O
relative	O
levels	O
in	O
monocytic	B-cell_type
than	O
non-monocytic	B-cell_type
cells	I-cell_type
,	O
suggesting	O
that	O
modification	O
of	O
Sp1	B-protein
,	O
such	O
as	O
phosphorylation	O
,	O
may	O
explain	O
how	O
the	O
Sp1	B-protein
site	O
mediates	O
monocytic	O
specific	O
promoter	O
activity	O
.	O

Tie	NULL
Journat	NULL
or	NULL
Brotocicat	NULL
Cremistay	NULL
©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

15	NULL
,	NULL
Issue	NULL
of	NULL
April	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

11425-11434	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Spl	NULL
Is	NULL
a	NULL
Critical	NULL
Factor	NULL
for	NULL
the	NULL
Monocytic	NULL
Specific	NULL
Expression	NULL
of	NULL
Human	NULL
CD14*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
3	NULL
,	NULL
1993	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
January	NULL
5	NULL
,	NULL
1994	NULL
)	NULL
Dong-Er	NULL
Zhangt	NULL
,	NULL
Christopher	NULL
J.	NULL
Hetherington	NULL
,	NULL
Shencao	NULL
Tang	NULL
,	NULL
Suzan	NULL
E.	NULL
Dziennis	NULL
,	NULL
David	NULL
A.	NULL
Gonzalez	NULL
,	NULL
Hui-Min	NULL
Chen	NULL
,	NULL
and	NULL
Daniel	NULL
G.	NULL
Tenen1	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
/Oncology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
and	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
CD14	NULL
is	NULL
a	NULL
membrane	NULL
glycoprotein	NULL
expressed	NULL
specifically	NULL
on	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
is	NULL
markedly	NULL
increased	NULL
during	NULL
the	NULL
process	NULL
of	NULL
monocyte	NULL
differentiation	NULL
.	NULL

In	NULL
order	NULL
to	NULL
study	NULL
CD14	NULL
gene	NULL
regulation	NULL
,	NULL
the	NULL
human	NULL
CD14	NULL
gene	NULL
was	NULL
cloned	NULL
from	NULL
a	NULL
partial	NULL
EcoRI	NULL
digested	NULL
chromosome	NULL
5	NULL
library	NULL
.	NULL

A	NULL
5.5-kilobase	NULL
genomic	NULL
clone	NULL
contained	NULL
the	NULL
full-length	NULL
CD14	NULL
coding	NULL
sequence	NULL
and	NULL
4.2	NULL
kilobases	NULL
of	NULL
5'-upstream	NULL
sequence	NULL
.	NULL

One	NULL
major	NULL
and	NULL
one	NULL
minor	NULL
transcription	NULL
start	NULL
site	NULL
were	NULL
identified	NULL
101	NULL
and	NULL
130	NULL
base	NULL
pairs	NULL
(	NULL
bp	NULL
)	NULL
upstream	NULL
,	NULL
respectively	NULL
,	NULL
from	NULL
the	NULL
protein	NULL
translation	NULL
start	NULL
ATG	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
containing	NULL
128	NULL
bp	NULL
of	NULL
upstream	NULL
sequence	NULL
had	NULL
strong	NULL
,	NULL
monocyte-specific	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
CD14	NULL
positive	NULL
monocytic	NULL
cell	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
non-monocytic	NULL
cell	NULL
lines	NULL
Hela	NULL
and	NULL
REX	NULL
.	NULL

Four	NULL
regions	NULL
in	NULL
this	NULL
DNA	NULL
fragment	NULL
interact	NULL
with	NULL
nuclear	NULL
proteins	NULL
isolated	NULL
from	NULL
monocytic	NULL
cells	NULL
.	NULL

The	NULL
Spl	NULL
transcription	NULL
factor	NULL
bound	NULL
to	NULL
three	NULL
different	NULL
regions	NULL
in	NULL
the	NULL
CD14	NULL
promoter	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
major	NULL
Spl	NULL
binding	NULL
site	NULL
(	NULL
-110	NULL
bp	NULL
)	NULL
decreased	NULL
tissue-specific	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
these	NULL
results	NULL
,	NULL
together	NULL
with	NULL
transactivation	NULL
experiments	NULL
,	NULL
demonstrate	NULL
that	NULL
Sp1	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
tissue-specific	NULL
expression	NULL
of	NULL
CD14	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

CD14	NULL
Spl	NULL
site	NULL
oligonucleotides	NULL
bound	NULL
preferentially	NULL
to	NULL
a	NULL
105-kDa	NULL
Spl	NULL
species	NULL
,	NULL
which	NULL
is	NULL
present	NULL
in	NULL
higher	NULL
relative	NULL
levels	NULL
in	NULL
monocytic	NULL
than	NULL
non-monocytic	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
modification	NULL
of	NULL
Spl	NULL
,	NULL
such	NULL
as	NULL
phosphorylation	NULL
,	NULL
may	NULL
explain	NULL
how	NULL
the	NULL
Spl	NULL
site	NULL
mediates	NULL
monocytic	NULL
specific	NULL
promoter	NULL
activity	NULL
.	NULL

Monocytes/macrophages	NULL
are	NULL
important	NULL
leukocytes	NULL
in	NULL
the	NULL
circulating	NULL
blood	NULL
and	NULL
in	NULL
almost	NULL
every	NULL
tissue	NULL
of	NULL
the	NULL
human	NULL
body	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
specific	NULL
immune	NULL
responses	NULL
and	NULL
in	NULL
nonspecific	NULL
defense	NULL
against	NULL
infection	NULL
and	NULL
malignancy	NULL
(	NULL
Ziegler-Heitbrock	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanism	NULL
of	NULL
development	NULL
of	NULL
this	NULL
cell	NULL
lineage	NULL
from	NULL
bone	NULL
marrow	NULL
pluripotent	NULL
stem	NULL
cells	NULL
is	NULL
still	NULL
poorly	NULL
understood	NULL
.	NULL

One	NULL
way	NULL
to	NULL
approach	NULL
this	NULL
problem	NULL
is	NULL
to	NULL
study	NULL
the	NULL
regulation	NULL
of	NULL
monocyte-specific	NULL
genes	NULL
.	NULL

Since	NULL
tissue-specific	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
to	NULL
a	NULL
significant	NULL
degree	NULL
by	NULL
specific	NULL
trans-activators	NULL
,	NULL
characterizing	NULL
the	NULL
fac-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
CA41456	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
``	NULL
/EMBL	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
UOO699	NULL
.	NULL

+	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
RE	NULL
217	NULL
,	NULL
330	NULL
Brookline	NULL
Ave.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02215	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
617-735-4125	NULL
;	NULL
Fax	NULL
:	NULL
617-735-3299	NULL
.	NULL

§	NULL
Current	NULL
address	NULL
:	NULL
Harvard	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

«	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

tors	NULL
involved	NULL
in	NULL
lineage-specific	NULL
gene	NULL
regulation	NULL
should	NULL
reveal	NULL
insights	NULL
into	NULL
the	NULL
mechanisms	NULL
of	NULL
monocyte/macrophage	NULL
lineage	NULL
development	NULL
and	NULL
activation	NULL
.	NULL

Furthermore	NULL
,	NULL
since	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
,	NULL
the	NULL
most	NULL
common	NULL
form	NULL
of	NULL
acute	NULL
leukemia	NULL
in	NULL
adults	NULL
,	NULL
represents	NULL
a	NULL
failure	NULL
of	NULL
normal	NULL
myeloid	NULL
(	NULL
monocytic	NULL
and	NULL
neutrophilic	NULL
)	NULL
differentiation	NULL
,	NULL
characterizing	NULL
the	NULL
factors	NULL
involved	NULL
in	NULL
normal	NULL
monocytic	NULL
development	NULL
may	NULL
supply	NULL
valuable	NULL
information	NULL
related	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
.	NULL

CD14	NULL
(	NULL
previously	NULL
known	NULL
as	NULL
gp55	NULL
,	NULL
My4	NULL
,	NULL
and	NULL
My23	NULL
)	NULL
is	NULL
a	NULL
monocytic	NULL
differentiation	NULL
marker	NULL
and	NULL
a	NULL
receptor	NULL
for	NULL
the	NULL
complex	NULL
composed	NULL
of	NULL
lipopolysaccharide	NULL
and	NULL
lipopolysaccharide-binding	NULL
protein	NULL
(	NULL
Haziot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Simmons	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Wright	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
CD14	NULL
using	NULL
monoclonal	NULL
antibodies	NULL
demonstrate	NULL
it	NULL
is	NULL
a	NULL
specific	NULL
marker	NULL
for	NULL
monocytic	NULL
cells	NULL
,	NULL
with	NULL
trace	NULL
amounts	NULL
detected	NULL
in	NULL
activated	NULL
granulocytes	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1981	NULL
;	NULL
Ball	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
)	NULL
.	NULL

Little	NULL
or	NULL
no	NULL
CD14	NULL
is	NULL
expressed	NULL
in	NULL
monocytic	NULL
precursors	NULL
,	NULL
and	NULL
the	NULL
receptor	NULL
is	NULL
strongly	NULL
up-regulated	NULL
during	NULL
the	NULL
course	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Studies	NULL
of	NULL
CD14	NULL
expression	NULL
using	NULL
the	NULL
human	NULL
CD14	NULL
cDNA	NULL
demonstrate	NULL
that	NULL
expression	NULL
of	NULL
CD14	NULL
mRNA	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
matches	NULL
that	NULL
of	NULL
the	NULL
surface	NULL
expression	NULL
(	NULL
Simmons	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

When	NULL
promyeloid	NULL
and	NULL
monoblast	NULL
cell	NULL
lines	NULL
are	NULL
treated	NULL
with	NULL
monocytic	NULL
differentiation	NULL
inducers	NULL
,	NULL
such	NULL
1,25-dihy-droxyvitamin	NULL
D	NULL
,	NULL
,	NULL
the	NULL
accumulation	NULL
of	NULL
CD14	NULL
mRNA	NULL
is	NULL
increased	NULL
in	NULL
parallel	NULL
with	NULL
surface	NULL
expression	NULL
(	NULL
Simmons	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Oberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

This	NULL
up-regulation	NULL
of	NULL
CD14	NULL
expression	NULL
is	NULL
mediated	NULL
mainly	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
,	NULL
``	NULL
as	NULL
is	NULL
the	NULL
reduction	NULL
of	NULL
CD14	NULL
expression	NULL
by	NULL
interleukin	NULL
4	NULL
(	NULL
Lauener	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
transcription	NULL
factors	NULL
mediating	NULL
tissue-specific	NULL
expression	NULL
and	NULL
differentiation	NULL
related	NULL
up-regulation	NULL
of	NULL
CD14	NULL
have	NULL
not	NULL
been	NULL
defined	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
murine	NULL
CD14	NULL
promoter	NULL
has	NULL
been	NULL
isolated	NULL
and	NULL
shown	NULL
to	NULL
direct	NULL
tissue-specific	NULL
expression	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
transient	NULL
transfections	NULL
(	NULL
Matsuura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
investigators	NULL
identified	NULL
an	NULL
upstream	NULL
element	NULL
which	NULL
was	NULL
capable	NULL
of	NULL
binding	NULL
nuclear	NULL
proteins	NULL
in	NULL
macrophage	NULL
cell	NULL
lines	NULL
and	NULL
could	NULL
enhance	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
element	NULL
played	NULL
an	NULL
important	NULL
role	NULL
in	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
murine	NULL
CD14	NULL
promoter	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
report	NULL
the	NULL
isolation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
CD14	NULL
gene	NULL
,	NULL
the	NULL
identification	NULL
of	NULL
tissue-specific	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
first	NULL
128	NULL
bp	NULL
``	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
description	NULL
of	NULL
the	NULL
protein-DNA	NULL
interactions	NULL
in	NULL
this	NULL
region	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
.	NULL

These	NULL
studies	NULL
demonstrate	NULL
that	NULL
the	NULL
Spl	NULL
transcription	NULL
factor	NULL
,	NULL
previously	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
other	NULL
monocytic	NULL
gene	NULL
promoters	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
also	NULL
contributes	NULL
significantly	NULL
to	NULL
the	NULL
monocytic	NULL
specific	NULL
expression	NULL
of	NULL
CD14	NULL
.	NULL
'	NULL

D.-E.	NULL
Zhang	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
RSV-hGH	NULL
,	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
human	NULL
growth	NULL
hormone	NULL
;	NULL
RB	NULL
,	NULL
retinoblastoma	NULL
.	NULL

11425	NULL
11426	NULL
EXPERIMENTAL	NULL
PROCEDURES	NULL
Cloning	NULL
of	NULL
the	NULL
CD14	NULL
Gene-A	NULL
partial	NULL
EcoRI-digested	NULL
human	NULL
chromosome	NULL
5	NULL
genomic	NULL
library	NULL
(	NULL
ATCC	NULL
57775	NULL
)	NULL
constructed	NULL
in	NULL
Charon	NULL
40	NULL
was	NULL
screened	NULL
with	NULL
a	NULL
P-labeled	NULL
CD14	NULL
cDNA	NULL
(	NULL
Simmons	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

A	NULL
clone	NULL
with	NULL
a	NULL
5.5-kb	NULL
EcoRI	NULL
insert	NULL
was	NULL
isolated	NULL
and	NULL
identified	NULL
with	NULL
Southern	NULL
blotting	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Simmons	NULL
et	NULL
.	NULL

al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
5.5-kb	NULL
insert	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pUC18	NULL
to	NULL
form	NULL
p-5.5kCD14	NULL
.	NULL

A	NULL
restriction	NULL
map	NULL
was	NULL
generated	NULL
by	NULL
single	NULL
and	NULL
double	NULL
digestion	NULL
with	NULL
a	NULL
group	NULL
of	NULL
restriction	NULL
enzymes	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
both	NULL
strands	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
(	NULL
Sanger	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1977	NULL
)	NULL
.	NULL

Transcription	NULL
factor	NULL
binding	NULL
site	NULL
consensus	NULL
sequences	NULL
were	NULL
identified	NULL
by	NULL
searching	NULL
the	NULL
transcription	NULL
factor	NULL
data	NULL
base	NULL
(	NULL
Ghosh	NULL
,	NULL
1992	NULL
)	NULL
using	NULL
the	NULL
Dynamic	NULL
program	NULL
supplied	NULL
by	NULL
the	NULL
Biomolecular	NULL
Engineering	NULL
Research	NULL
Center	NULL
at	NULL
Boston	NULL
University	NULL
.	NULL

RNase	NULL
Protection	NULL
Analysis-Human	NULL
monocyte	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
blood	NULL
monocytes	NULL
by	NULL
Ficoll-Hypaque	NULL
sedimentation	NULL
and	NULL
adherence	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Pahl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
CD14	NULL
gene	NULL
extending	NULL
from	NULL
4	NULL
to	NULL
328	NULL
bp	NULL
upstream	NULL
of	NULL
translation	NULL
start	NULL
ATG	NULL
was	NULL
subcloned	NULL
by	NULL
PCR	NULL
using	NULL
p-5.5kCD14	NULL
as	NULL
a	NULL
template	NULL
,	NULL
primer	NULL
A	NULL
(	NULL
5'-CGGGATCCCTGAGTCATCAGGACAC-3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
primer	NULL
B	NULL
(	NULL
5'-GGGGTACCCCGATAAGTCTTCCGAACCTC-3	NULL
'	NULL
)	NULL
.	NULL

After	NULL
digestion	NULL
with	NULL
BamHI	NULL
and	NULL
KpnI	NULL
,	NULL
the	NULL
PCR	NULL
product	NULL
was	NULL
subcloned	NULL
into	NULL
pBlue-script	NULL
(	NULL
KS~	NULL
)	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
linearized	NULL
with	NULL
BamHI	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
PCR	NULL
fragment	NULL
was	NULL
confirmed	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
p-5.5kCD14	NULL
.	NULL

A	NULL
[	NULL
*°P	NULL
]	NULL
JCTP-labeled	NULL
antisense	NULL
transcript	NULL
was	NULL
prepared	NULL
with	NULL
T3	NULL
polymerase	NULL
based	NULL
on	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

5	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
in	NULL
vitro	NULL
transcript	NULL
was	NULL
heated	NULL
to	NULL
85	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
yeast	NULL
tRNA	NULL
,	NULL
HeLa	NULL
cell	NULL
RNA	NULL
,	NULL
or	NULL
monocyte	NULL
RNA	NULL
and	NULL
annealed	NULL
overnight	NULL
at	NULL
45	NULL
°C	NULL
.	NULL

Samples	NULL
were	NULL
digested	NULL
with	NULL
RNase	NULL
A	NULL
and	NULL
RNase	NULL
T1	NULL
as	NULL
described	NULL
(	NULL
Ausabel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
,	NULL
8.3	NULL
m	NULL
urea	NULL
gel	NULL
.	NULL

M13	NULL
mp18	NULL
sequence	NULL
obtained	NULL
using	NULL
the	NULL
``	NULL
-40	NULL
primer	NULL
``	NULL
(	NULL
5'-GTTTTC-CCAGTCACGAC-3	NULL
'	NULL
)	NULL
(	NULL
U.	NULL
S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
was	NULL
used	NULL
as	NULL
size	NULL
markers	NULL
.	NULL

Autoradiographs	NULL
were	NULL
performed	NULL
with	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
at	NULL
-80	NULL
°C	NULL
for	NULL
16	NULL
h.	NULL
Cell	NULL
Culture-Human	NULL
T	NULL
lymphoblastic	NULL
REX	NULL
cells	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
James	NULL
Griffin	NULL
,	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Institute	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
and	NULL
2	NULL
mm	NULL
L-glutamine	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
human	NULL
monocytic	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
propagated	NULL
as	NULL
described	NULL
(	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Human	NULL
cervical	NULL
carcinoma	NULL
Hela	NULL
cells	NULL
(	NULL
ATCC	NULL
CCL	NULL
2	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
media	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
newborn	NULL
calf	NULL
serum	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
and	NULL
2	NULL
mm	NULL
1-glutamine	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
.	NULL

Hela	NULL
S8	NULL
cells	NULL
(	NULL
ATCC	NULL
CCL	NULL
2.2	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
sus-pension-minimum	NULL
essential	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
calf	NULL
serum	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
and	NULL
2	NULL
mx	NULL
L-glutamine	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
.	NULL

Drosophila	NULL
Schneider	NULL
S2	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Schneider	NULL
medium	NULL
(	NULL
Sigma	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat	NULL
in-activated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
)	NULL
and	NULL
in	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
.	NULL

Northern	NULL
Blotting	NULL
Analysis-Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
by	NULL
the	NULL
guanidium	NULL
isothiocyanate	NULL
method	NULL
(	NULL
Chirgwin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
)	NULL
.	NULL

RNA	NULL
(	NULL
25	NULL
pg/lane	NULL
)	NULL
was	NULL
denatured	NULL
in	NULL
formamide/	NULL
formaldehyde	NULL
followed	NULL
by	NULL
electrophoresis	NULL
in	NULL
1	NULL
%	NULL
agarose/formaldehyde	NULL
gels	NULL
.	NULL

RNA	NULL
was	NULL
then	NULL
transferred	NULL
to	NULL
Biotrans	NULL
nylon	NULL
membrane	NULL
(	NULL
ICN	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
probed	NULL
sequentially	NULL
with	NULL
a	NULL
CD14	NULL
cDNA	NULL
fragment	NULL
(	NULL
Simmons	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
28	NULL
S	NULL
RNA	NULL
oligonucleotide	NULL
(	NULL
5'-AACGAT-CAGAGTAGTGG-3	NULL
'	NULL
)	NULL
for	NULL
internal	NULL
control	NULL
of	NULL
RNA	NULL
loading	NULL
.	NULL

The	NULL
condition	NULL
for	NULL
probe	NULL
labeling	NULL
,	NULL
membrane	NULL
hybridization	NULL
,	NULL
washing	NULL
,	NULL
and	NULL
autoradiog-raphy	NULL
were	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Pahl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Transient	NULL
-	NULL
Transfections-The	NULL
|	NULL
p-4.2kCD14-lue	NULL
,	NULL
-	NULL
p-2.8kCD14-luc	NULL
,	NULL
p-2.3kCD14-luc	NULL
,	NULL
and	NULL
p-128CD14-lue	NULL
were	NULL
constructed	NULL
by	NULL
digestion	NULL
of	NULL
p-5.5kCD14	NULL
with	NULL
EcoRUSacl	NULL
,	NULL
BgilVSacl	NULL
,	NULL
EcoRV/Sacl	NULL
,	NULL
and	NULL
SspUSacI	NULL
,	NULL
isolation	NULL
of	NULL
4.2-kb	NULL
,	NULL
2.8-kb	NULL
,	NULL
2.3-kb	NULL
,	NULL
and	NULL
128-bp	NULL
DNA	NULL
fragments	NULL
,	NULL
and	NULL
inserting	NULL
each	NULL
fragment	NULL
into	NULL
the	NULL
promoterless	NULL
luciferase	NULL
reporter	NULL
vector	NULL
pXP2	NULL
,	NULL
respectively	NULL
(	NULL
Nordeen	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

p-227CD14-lue	NULL
was	NULL
constructed	NULL
with	NULL
the	NULL
BamHI-	NULL
and	NULL
Sacl-digested	NULL
PCR	NULL
fragment	NULL
(	NULL
p-5.5kCD14	NULL
as	NULL
template	NULL
with	NULL
above	NULL
primer	NULL
A	NULL
and	NULL
primer	NULL
B	NULL
)	NULL
and	NULL
inserted	NULL
into	NULL
pXP2	NULL
.	NULL

The	NULL
p-449CD14-lue	NULL
was	NULL
constructed	NULL
with	NULL
the	NULL
BamHI-	NULL
and	NULL
Sacl-digested	NULL
PCR	NULL
fragment	NULL
(	NULL
p-5.5kCD14	NULL
as	NULL
template	NULL
with	NULL
primer	NULL
E	NULL
:	NULL
55-CGGGATC-CAGGGACTTGGATTTGG-3	NULL
'	NULL
and	NULL
above	NULL
primer	NULL
B	NULL
)	NULL
and	NULL
inserted	NULL
into	NULL
pXP2	NULL
.	NULL

Each	NULL
PCR	NULL
construct	NULL
was	NULL
sequenced	NULL
to	NULL
confirm	NULL
its	NULL
identity	NULL
with	NULL
the	NULL
CD14	NULL
genomic	NULL
sequence	NULL
.	NULL

Mono	NULL
Mac	NULL
6	NULL
and	NULL
REX	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
at	NULL
960	NULL
microfarads	NULL
and	NULL
230	NULL
and	NULL
280	NULL
V	NULL
,	NULL
respectively	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
in	NULL
Iscove	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
at	NULL
960	NULL
microfarads	NULL
and	NULL
150	NULL
V.	NULL
The	NULL
detailed	NULL
transfection	NULL
procedures	NULL
are	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Pahl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
5	NULL
h	NULL
post-transfection	NULL
in	NULL
0.5	NULL
ml	NULL
Sp1	NULL
Directs	NULL
Monocytic	NULL
Specific	NULL
CD14	NULL
Promoter	NULL
Expression	NULL
of	NULL
lysis	NULL
buffer	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Pahl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
levels	NULL
of	NULL
growth	NULL
hormone	NULL
expressed	NULL
from	NULL
2	NULL
ug	NULL
of	NULL
co-transfected	NULL
plasmid	NULL
containing	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
promoter	NULL
directing	NULL
human	NULL
growth	NULL
hormone	NULL
gene	NULL
expression	NULL
(	NULL
RSV-hGH	NULL
)	NULL
,	NULL
and	NULL
data	NULL
are	NULL
presented	NULL
in	NULL
relative	NULL
light	NULL
units	NULL
per	NULL
ng	NULL
of	NULL
growth	NULL
hormone	NULL
.	NULL

Growth	NULL
hormone	NULL
concentrations	NULL
were	NULL
measured	NULL
by	NULL
radioimmunoassay	NULL
(	NULL
Nichols	NULL
Institute	NULL
,	NULL
San	NULL
Juan	NULL
Capistrano	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
Footprinting-p-227CD14-luc	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
Xhol	NULL
to	NULL
release	NULL
the	NULL
promoter	NULL
fragment	NULL
extending	NULL
from	NULL
bp	NULL
-227	NULL
to	NULL
bp	NULL
+80	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
from	NULL
the	NULL
vector	NULL
pXP2	NULL
and	NULL
end	NULL
labeled	NULL
with	NULL
*P	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Nuclear	NULL
protein	NULL
{	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
ug	NULL
of	NULL
double	NULL
stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
)	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
purified	NULL
Spl	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
or	NULL
1	NULL
ul	NULL
of	NULL
purified	NULL
AP-2	NULL
(	NULL
Promega	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
DNA	NULL
probe	NULL
in	NULL
a	NULL
total	NULL
of	NULL
20	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
my	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
30	NULL
mm	NULL
KCI	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mx	NULL
EDTA	NULL
,	NULL
0.4	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
30	NULL
min	NULL
at	NULL
0	NULL
°C	NULL
.	NULL

Nuclear	NULL
Extracts-Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
REX	NULL
cells	NULL
,	NULL
and	NULL
HeLa	NULL
S3	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
4	NULL
x	NULL
10°	NULL
cells/ml	NULL
and	NULL
harvested	NULL
for	NULL
nuclear	NULL
protein	NULL
ex-traction	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Approximately	NULL
15	NULL
mg	NULL
of	NULL
nuclear	NULL
protein	NULL
were	NULL
prepared	NULL
from	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay-*P-Labeled	NULL
double	NULL
stranded	NULL
oligonucleotides	NULL
for	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Pah	NULL
!	NULL

et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
conditions	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
for	NULL
DNase	NULL
I	NULL
footprinting	NULL
,	NULL
except	NULL
for	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ng	NULL
of	NULL
double	NULL
stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
electro-phoresed	NULL
at	NULL
10	NULL
V/em	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
bisacrylamide	NULL
:	NULL
acrylamide	NULL
=	NULL
1:29	NULL
)	NULL
in	NULL
0.5	NULL
x	NULL
TBE	NULL
(	NULL
45	NULL
mm	NULL
Tris	NULL
borate	NULL
,	NULL
45	NULL
mm	NULL
boric	NULL
acid	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
Lanes	NULL
8	NULL
and	NULL
9	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
a	NULL
polyclonal	NULL
rabbit	NULL
antisera	NULL
raised	NULL
against	NULL
bacterially	NULL
expressed	NULL
Sp1	NULL
,	NULL
or	NULL
preimmune	NULL
control	NULL
serum	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
added	NULL
to	NULL
the	NULL
nuclear	NULL
extract	NULL
and	NULL
prein-cubated	NULL
for	NULL
15	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

For	NULL
on-rate	NULL
binding	NULL
experiments	NULL
,	NULL
samples	NULL
were	NULL
loaded	NULL
to	NULL
the	NULL
polyacrylamide	NULL
gel	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
min	NULL
after	NULL
the	NULL
start	NULL
of	NULL
binding	NULL
reaction	NULL
.	NULL

For	NULL
off-rate	NULL
binding	NULL
experiments	NULL
,	NULL
a	NULL
25-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
self-oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
DNA/protein	NULL
mixture	NULL
20	NULL
min	NULL
after	NULL
the	NULL
initial	NULL
binding	NULL
reaction	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
loaded	NULL
on	NULL
the	NULL
polyacrylamide	NULL
gel	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
10	NULL
,	NULL
and	NULL
15	NULL
min	NULL
after	NULL
adding	NULL
the	NULL
self-competitor	NULL
.	NULL

Site-directed	NULL
Mutagenesis-Mutation	NULL
in	NULL
the	NULL
Spl	NULL
site	NULL
at	NULL
bp	NULL
-110	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
was	NULL
generated	NULL
using	NULL
oligonucleotides	NULL
carrying	NULL
point	NULL
mutations	NULL
(	NULL
Zaret	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
mutated	NULL
CD14	NULL
promoter	NULL
fragment	NULL
was	NULL
generated	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Plasmid	NULL
p-227CD14-luc	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
with	NULL
primer	NULL
A	NULL
(	NULL
as	NULL
indicated	NULL
above	NULL
)	NULL
and	NULL
primer	NULL
C	NULL
(	NULL
5'-GGGGTACCTTCCTTTCCTGG-3	NULL
'	NULL
)	NULL
to	NULL
generate	NULL
PCR	NULL
fragment	NULL
1	NULL
;	NULL
with	NULL
primer	NULL
B	NULL
(	NULL
as	NULL
indicated	NULL
above	NULL
)	NULL
and	NULL
primer	NULL
D	NULL
(	NULL
5-GGGGTACCTG-GCTCGGAGG-3	NULL
'	NULL
)	NULL
to	NULL
generate	NULL
PCR	NULL
fragment	NULL
2	NULL
.	NULL

PCR	NULL
fragment	NULL
1	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
KpnI	NULL
.	NULL

PCR	NULL
fragment	NULL
2	NULL
was	NULL
digested	NULL
with	NULL
KpnI	NULL
and	NULL
Sacl	NULL
.	NULL

Both	NULL
digested	NULL
PCR	NULL
fragments	NULL
were	NULL
ligated	NULL
with	NULL
BamHI	NULL
and	NULL
Sacl	NULL
digested	NULL
vector	NULL
pXP2	NULL
to	NULL
construct	NULL
p-227	NULL
(	NULL
m110	NULL
)	NULL
CD14-luc	NULL
.	NULL

Sequence	NULL
of	NULL
the	NULL
mutant	NULL
construct	NULL
was	NULL
confirmed	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
the	NULL
CD14	NULL
gene	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
.	NULL

The	NULL
mutated	NULL
construct	NULL
p-227	NULL
(	NULL
m110	NULL
)	NULL
CD14-lue	NULL
changed	NULL
the	NULL
sequence	NULL
GGG	NULL
at	NULL
bp	NULL
-110	NULL
to	NULL
~108	NULL
to	NULL
TAC	NULL
.	NULL

Transactivation	NULL
of	NULL
Promoter	NULL
in	NULL
Schneider	NULL
Cells-Schneider	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
co-precipitation	NULL
method	NULL
as	NULL
described	NULL
(	NULL
Chen	NULL
and	NULL
Okayama	NULL
,	NULL
1988	NULL
)	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
;	NULL
with	NULL
and	NULL
without	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
Spl	NULL
expression	NULL
vector	NULL
pPacSpl	NULL
(	NULL
Courey	NULL
and	NULL
Tjian	NULL
,	NULL
1988	NULL
)	NULL
;	NULL
and	NULL
sonicated	NULL
double	NULL
stranded	NULL
salmon	NULL
sperm	NULL
DNA	NULL
to	NULL
a	NULL
total	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
DNA	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Pah	NULL
!	NULL

et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Southwestern	NULL
Blotting-This	NULL
was	NULL
performed	NULL
following	NULL
a	NULL
published	NULL
protocol	NULL
(	NULL
Morabito	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
proteins	NULL
were	NULL
prepared	NULL
by	NULL
adding	NULL
the	NULL
SDS	NULL
sample	NULL
buffer	NULL
directly	NULL
to	NULL
fresh	NULL
cell	NULL
pellets	NULL
(	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Total	NULL
protein	NULL
from	NULL
1.5	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
6.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
(	NULL
bisacrylamide	NULL
:	NULL
acrylamide	NULL
=	NULL
1:29	NULL
)	NULL
using	NULL
the	NULL
Laemmli	NULL
buffer	NULL
system	NULL
(	NULL
Laemmli	NULL
,	NULL
1970	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
BA55	NULL
)	NULL
by	NULL
electro-blotting	NULL
at	NULL
0.4	NULL
A	NULL
for	NULL
14	NULL
h.	NULL
Prehybridization	NULL
was	NULL
performed	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
P	NULL
end-labeled	NULL
CD14	NULL
Sp1	NULL
binding	NULL
oligonucleotide	NULL
in	NULL
15	NULL
ml	NULL
of	NULL
hybridization	NULL
buffer	NULL
(	NULL
0.25	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
,	NULL
20	NULL
pg/ml	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
25	NULL
mu	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
3	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
5	NULL
mx	NULL
dithiothreitol	NULL
)	NULL
.	NULL

Nitrocellulose	NULL
membranes	NULL
were	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
in	NULL
hybridization	NULL
buffer	NULL
Sp1	NULL
Directs	NULL
Monocytic	NULL
Specific	NULL
CD14	NULL
Promoter	NULL
Expression	NULL
without	NULL
probe	NULL
DNA	NULL
,	NULL
briefly	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
on	NULL
x-ray	NULL
film	NULL
(	NULL
Kodak	NULL
,	NULL
XAR-5	NULL
)	NULL
.	NULL

Western	NULL
Blotting-Following	NULL
Southwestern	NULL
blotting	NULL
and	NULL
autoradiog-raphy	NULL
,	NULL
the	NULL
same	NULL
nitrocellulose	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
with	NULL
gentle	NULL
agitation	NULL
to	NULL
remove	NULL
the	NULL
probe	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
5	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
Sp1	NULL
polyclonal	NULL
antibody	NULL
(	NULL
diluted	NULL
1:1000	NULL
)	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
1	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
,	NULL
0.02	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
Tris-buffered	NULL
saline	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
antibody	NULL
(	NULL
diluted	NULL
1:1500	NULL
,	NULL
Bio-Rad	NULL
)	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
containing	NULL
1	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
and	NULL
0.02	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
containing	NULL
0.02	NULL
%	NULL
Triton	NULL
X-100	NULL
and	NULL
once	NULL
with	NULL
Tris-buffered	NULL
saline	NULL
.	NULL

Color	NULL
development	NULL
utilized	NULL
4-chloro-1-naphthol	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

The	NULL
colored	NULL
Spl	NULL
bands	NULL
on	NULL
the	NULL
Western	NULL
blot	NULL
were	NULL
quantitated	NULL
by	NULL
scanning	NULL
on	NULL
a	NULL
ScanJet	NULL
Plus	NULL
Scanner	NULL
(	NULL
Hewlett-Packard	NULL
)	NULL
followed	NULL
by	NULL
densitometry	NULL
analysis	NULL
using	NULL
ImageQuant	NULL
``	NULL
Software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

RESULTS	NULL
Cloning	NULL
and	NULL
Characterization	NULL
of	NULL
the	NULL
Human	NULL
CD14	NULL
Gene-Since	NULL
the	NULL
transcription	NULL
of	NULL
CD14	NULL
mRNA	NULL
is	NULL
strongly	NULL
up-regulated	NULL
during	NULL
myelomonocytic	NULL
differentiation	NULL
,	NULL
we	NULL
analyzed	NULL
its	NULL
genomic	NULL
structure	NULL
to	NULL
further	NULL
study	NULL
key	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
CD14	NULL
promoter	NULL
.	NULL

The	NULL
CD14	NULL
gene	NULL
has	NULL
been	NULL
mapped	NULL
to	NULL
human	NULL
chromosome	NULL
5q23-31	NULL
(	NULL
Goyert	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Southern	NULL
blot	NULL
analysis	NULL
of	NULL
genomic	NULL
DNA	NULL
with	NULL
the	NULL
full-length	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
demonstrated	NULL
that	NULL
CD14	NULL
is	NULL
a	NULL
single	NULL
copy	NULL
gene	NULL
(	NULL
Simmons	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

A	NULL
partial	NULL
EcoRI-digested	NULL
chromosome	NULL
5-specific	NULL
genomic	NULL
library	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
was	NULL
used	NULL
to	NULL
clone	NULL
the	NULL
CD14	NULL
gene	NULL
.	NULL

One	NULL
clone	NULL
was	NULL
characterized	NULL
and	NULL
demonstrated	NULL
to	NULL
have	NULL
a	NULL
single	NULL
5.5-kb	NULL
insert	NULL
,	NULL
which	NULL
was	NULL
the	NULL
same	NULL
size	NULL
as	NULL
the	NULL
single	NULL
band	NULL
detected	NULL
on	NULL
Southern	NULL
blots	NULL
with	NULL
EcoRI	NULL
digested	NULL
DNA	NULL
(	NULL
Simmons	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
5.5-kb	NULL
insert	NULL
hybridized	NULL
to	NULL
an	NULL
oligonucleotide	NULL
made	NULL
from	NULL
the	NULL
most	NULL
5'-region	NULL
of	NULL
the	NULL
coding	NULL
sequence	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
was	NULL
subcloned	NULL
into	NULL
pUC18	NULL
for	NULL
further	NULL
characterization	NULL
.	NULL

Sequence	NULL
analysis	NULL
confirmed	NULL
that	NULL
this	NULL
DNA	NULL
fragment	NULL
was	NULL
the	NULL
gene	NULL
for	NULL
CD14	NULL
.	NULL

There	NULL
is	NULL
a	NULL
single	NULL
88-bp	NULL
intron	NULL
immediately	NULL
after	NULL
the	NULL
ATG	NULL
translation	NULL
start	NULL
codon	NULL
.	NULL

Mapping	NULL
this	NULL
genomic	NULL
clone	NULL
indicated	NULL
that	NULL
the	NULL
3	NULL
'	NULL
end	NULL
was	NULL
colinear	NULL
with	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
cDNA	NULL
,	NULL
and	NULL
that	NULL
approximately	NULL
4.2	NULL
kb	NULL
of	NULL
the	NULL
genomic	NULL
clone	NULL
was	NULL
5	NULL
'	NULL
of	NULL
the	NULL
first	NULL
codon	NULL
for	NULL
translation	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
entire	NULL
gene	NULL
and	NULL
the	NULL
promoter	NULL
region	NULL
was	NULL
isolated	NULL
on	NULL
this	NULL
single	NULL
phage	NULL
.	NULL

The	NULL
5'-upstream	NULL
region	NULL
of	NULL
the	NULL
CD14	NULL
gene	NULL
was	NULL
sequenced	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Identification	NULL
of	NULL
CD14	NULL
Gene	NULL
Transcription	NULL
Initiation	NULL
Site-To	NULL
identify	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
CD14	NULL
gene	NULL
,	NULL
RNase	NULL
protection	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
radiolabeled	NULL
riboprobe	NULL
was	NULL
347	NULL
nucleotides	NULL
long	NULL
,	NULL
including	NULL
upstream	NULL
CD14	NULL
sequence	NULL
extending	NULL
from	NULL
4	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
ATG	NULL
.	NULL

When	NULL
this	NULL
probe	NULL
was	NULL
hybridized	NULL
to	NULL
total	NULL
RNA	NULL
from	NULL
human	NULL
monocytes	NULL
and	NULL
digested	NULL
with	NULL
RNases	NULL
,	NULL
it	NULL
generated	NULL
a	NULL
major	NULL
band	NULL
of	NULL
98	NULL
bp	NULL
and	NULL
a	NULL
minor	NULL
band	NULL
of	NULL
127	NULL
bp	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Lane	NULL
2	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
Hela	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Lane	NULL
1	NULL
)	NULL
and	NULL
tRNA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Lane	NULL
3	NULL
)	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
and	NULL
show	NULL
no	NULL
protected	NULL
bands	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
major	NULL
CD14	NULL
transcription	NULL
start	NULL
site	NULL
is	NULL
101	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
,	NULL
with	NULL
a	NULL
minor	NULL
start	NULL
site	NULL
130	NULL
bp	NULL
upstream	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
first	NULL
base	NULL
pair	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
is	NULL
numbered	NULL
as	NULL
+1	NULL
.	NULL

Sequence	NULL
Analysis	NULL
of	NULL
the	NULL
CD14	NULL
5'-Upstream	NULL
Region	NULL
Reveals	NULL
Consensus	NULL
Transcription	NULL
Factor	NULL
Binding	NULL
Sites-Sequence	NULL
analysis	NULL
of	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
identified	NULL
several	NULL
putative	NULL
binding	NULL
sites	NULL
of	NULL
transcription	NULL
factors	NULL
as	NULL
marked	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
sequence	NULL
CATAAA	NULL
at	NULL
-28	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
(	NULL
TATAAA	NULL
)	NULL
(	NULL
Greenblatt	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

There	NULL
is	NULL
no	NULL
typical	NULL
initiator	NULL
sequence	NULL
YAYTCYYY	NULL
around	NULL
the	NULL
transcription	NULL
start	NULL
sites	NULL
(	NULL
Smale	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Roeder	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

A	NULL
Spl	NULL
consensus	NULL
sequence	NULL
is	NULL
found	NULL
at	NULL
+20	NULL
(	NULL
Dynan	NULL
and	NULL
Tjian	NULL
,	NULL
11427	NULL
-474	NULL
CATGC	NULL
AGTTAAATAT	NULL
CTGAGGATAT	NULL
-451	NULL
yb	NULL
TCAGGGACTT	NULL
GGATTTGGTG	NULL
GCAGGAGATC	NULL
AACATAAACC	NULL
AAGACAAGGA	NULL
-401	NULL
[	NULL
AGAAGTCARh	NULL
carafoGaa®c	NULL
Armcracamtc	NULL
TcroccaTat	NULL
Arcoraccoc	NULL
-351	NULL
Api	NULL
Api	NULL
rrecaracrte	NULL
caororaTes	NULL
TaAcTGGoccTA	NULL
AGGCACTGAG	NULL
-301	NULL
ccarnr/cop	NULL
GATCATCCTT	NULL
TTCCCACACC	NULL
CACCAGAGAA	NULL
GGCTTAGGCT	NULL
CCCGAGTCAA	NULL
-251	NULL
CAGGGCATTC	NULL
A	NULL
E	NULL
;	NULL
l	NULL
CGCCEELPCAGGACAC	NULL
TGCCAGGAGA	NULL
-201	NULL
AP2	NULL
APL	NULL
CACAGAACCC	NULL
TAGATGCCCT	NULL
GCAGAATCCT	NULL
TCCTGTTACG	NULL
G'IECCCCTCC	NULL
~151	NULL
AP2	NULL
ETGAAACATC	NULL
CTTCATTGCA	NULL
ATATTTCCAG	NULL
GAAAGGAAGG	NULL
[	NULL
GEETC	NULL
-101	NULL
SP1	NULL
MAG	NULL
AGGTGGGGAG	NULL
GTGATCAGGG	NULL
TTCACAGAGG	NULL
AM	NULL
-~51	NULL
PU	NULL
.	NULL

1	NULL
Myb	NULL
ATGACATCCC	NULL
AGGATTACAT	NULL
TGTCAG	NULL
AGGCAGCCGA	NULL
AGAGTTCACA	NULL
-1	NULL
TATAA	NULL
*	NULL
AGTGTGAAGC	NULL
CTGGMGCCEEGCCG	NULL
CTGTGTAGGA	NULL
AAGAAGCTAA	NULL
+50	NULL
SP1	NULL
AGCACTTCCA	NULL
GAGCCTGTCC	NULL
GGAGCTCAGA	NULL
GGTTCGGAAG	NULL
ACTTATCGAC	NULL
+100	NULL
CATGgtgagt	NULL
gtagggtctt	NULL
...	NULL
..	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Human	NULL
CD14	NULL
5'-flanking	NULL
region	NULL
.	NULL

Sequence	NULL
was	NULL
obtained	NULL
from	NULL
both	NULL
strands	NULL
by	NULL
the	NULL
dideoxy	NULL
method	NULL
.	NULL

The	NULL
translation	NULL
start	NULL
site	NULL
ATG	NULL
is	NULL
underlined	NULL
.	NULL

The	NULL
major	NULL
and	NULL
minor	NULL
transcription	NULL
start	NULL
sites	NULL
are	NULL
marked	NULL
with	NULL
large	NULL
and	NULL
small	NULL
arrows	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
beginning	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
is	NULL
numbered	NULL
as	NULL
+1	NULL
.	NULL

Lower	NULL
case	NULL
letters	NULL
indicate	NULL
the	NULL
intron	NULL
sequence	NULL
.	NULL

The	NULL
shaded	NULL
boxes	NULL
are	NULL
putative	NULL
transacting	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
as	NULL
discussed	NULL
under	NULL
``	NULL
Results	NULL
.	NULL
``	NULL

Also	NULL
shaded	NULL
is	NULL
the	NULL
experimentally	NULL
detected	NULL
Sp1	NULL
site	NULL
at	NULL
bp	NULL
-110	NULL
.	NULL

The	NULL
asterisk	NULL
(	NULL
*	NULL
)	NULL
indicates	NULL
the	NULL
end	NULL
of	NULL
the	NULL
published	NULL
cDNA	NULL
sequence	NULL
at	NULL
bp	NULL
+27	NULL
(	NULL
Simmons	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
sequence	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
Genbank	NULL
data	NULL
base	NULL
(	NULL
accession	NULL
No	NULL
.	NULL

UOO699	NULL
)	NULL
.	NULL

1983	NULL
;	NULL
Letovsky	NULL
and	NULL
Dynan	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

A	NULL
potential	NULL
site	NULL
for	NULL
the	NULL
ets	NULL
family	NULL
member	NULL
PU.1	NULL
(	NULL
GAGGAA	NULL
)	NULL
is	NULL
located	NULL
at	NULL
-95	NULL
(	NULL
Klemsz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
there	NULL
are	NULL
two	NULL
Myb	NULL
sites	NULL
(	NULL
-55	NULL
,	NULL
-469	NULL
)	NULL
(	NULL
Weston	NULL
,	NULL
1992	NULL
)	NULL
,	NULL
3	NULL
AP-1	NULL
sites	NULL
(	NULL
-220	NULL
,	NULL
-385	NULL
,	NULL
-395	NULL
)	NULL
(	NULL
Wasylyk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
two	NULL
AP-2	NULL
sites	NULL
(	NULL
-235	NULL
,	NULL
-155	NULL
)	NULL
(	NULL
Williams	NULL
and	NULL
Tjian	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
one	NULL
CDP	NULL
(	NULL
CCATT	NULL
displacement	NULL
protein	NULL
)	NULL
site	NULL
(	NULL
-397	NULL
)	NULL
(	NULL
Skalnik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
human	NULL
CD14	NULL
sequence	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
recently	NULL
available	NULL
murine	NULL
CD14	NULL
upstream	NULL
sequence	NULL
(	NULL
Matsuura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
similarity	NULL
is	NULL
about	NULL
71	NULL
%	NULL
between	NULL
-200	NULL
and	NULL
+110	NULL
of	NULL
the	NULL
human	NULL
CD14	NULL
gene	NULL
with	NULL
100	NULL
%	NULL
match	NULL
in	NULL
many	NULL
smaller	NULL
regions	NULL
.	NULL

The	NULL
similarity	NULL
is	NULL
much	NULL
lower	NULL
further	NULL
upstream	NULL
of	NULL
this	NULL
region	NULL
.	NULL

Since	NULL
important	NULL
regulatory	NULL
sequences	NULL
are	NULL
more	NULL
conserved	NULL
during	NULL
evolution	NULL
,	NULL
these	NULL
similarities	NULL
suggest	NULL
the	NULL
region	NULL
from	NULL
bp	NULL
-200	NULL
to	NULL
+110	NULL
may	NULL
contain	NULL
tissue-specific	NULL
promoter	NULL
activity	NULL
.	NULL

Identification	NULL
of	NULL
CD14	NULL
Positive	NULL
Cell	NULL
Lines	NULL
to	NULL
Characterize	NULL
CD14	NULL
Promoter-To	NULL
study	NULL
the	NULL
tissue-specific	NULL
expression	NULL
of	NULL
CD14	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
identify	NULL
cell	NULL
lines	NULL
that	NULL
are	NULL
positive	NULL
for	NULL
expression	NULL
of	NULL
CD14	NULL
RNA	NULL
.	NULL

The	NULL
Mono	NULL
Mac	NULL
6	NULL
cell	NULL
line	NULL
is	NULL
perhaps	NULL
more	NULL
similar	NULL
to	NULL
mature	NULL
monocytes	NULL
than	NULL
other	NULL
cell	NULL
lines	NULL
available	NULL
(	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Surface	NULL
expression	NULL
of	NULL
CD14	NULL
protein	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
is	NULL
significantly	NULL
higher	NULL
than	NULL
the	NULL
monoblast	NULL
cell	NULL
line	NULL
U937	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
CD14	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
was	NULL
examined	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

As	NULL
shown	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
compared	NULL
to	NULL
HeLa	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
there	NULL
is	NULL
no	NULL
detectable	NULL
CD14	NULL
mRNA	NULL
,	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
CD14	NULL
mRNA	NULL
.	NULL

11428	NULL
1	NULL
2	NULL
3	NULL
*	NULL
--	NULL
300	NULL
-	NULL
250	NULL
-	NULL
200	NULL
-	NULL
150	NULL
127	NULL
--	NULL
100	NULL
98	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
CD14	NULL
transcription	NULL
start	NULL
site	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

Ten	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
Lane	NULL
1	NULL
)	NULL
,	NULL
human	NULL
monocytes	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
tRNA	NULL
(	NULL
Lane	NULL
3	NULL
)	NULL
were	NULL
hybridized	NULL
with	NULL
antisense	NULL
riboprobe	NULL
and	NULL
digested	NULL
with	NULL
RNases	NULL
A	NULL
and	NULL
T	NULL
,	NULL
.	NULL

The	NULL
size	NULL
of	NULL
undigested	NULL
347-nucleotide	NULL
riboprobe	NULL
is	NULL
marked	NULL
with	NULL
an	NULL
asterisk	NULL
(	NULL
*	NULL
)	NULL
.	NULL

Arrows	NULL
on	NULL
the	NULL
left	NULL
side	NULL
of	NULL
the	NULL
panel	NULL
point	NULL
to	NULL
the	NULL
127-	NULL
and	NULL
98-nucleotide	NULL
protected	NULL
fragments	NULL
.	NULL

Lanes	NULL
G	NULL
,	NULL
A	NULL
,	NULL
T	NULL
,	NULL
and	NULL
C	NULL
,	NULL
are	NULL
M13	NULL
mp18	NULL
sequencing	NULL
size	NULL
markers	NULL
.	NULL

The	NULL
immature	NULL
T	NULL
cell	NULL
line	NULL
REX	NULL
,	NULL
undifferentiated	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
and	NULL
undifferentiated	NULL
promyelocytic	NULL
cell	NULL
line	NULL
HL-60	NULL
did	NULL
not	NULL
show	NULL
any	NULL
CD14	NULL
mRNA	NULL
in	NULL
Northern	NULL
blot	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Mono	NULL
Mac	NULL
6	NULL
would	NULL
be	NULL
an	NULL
excellent	NULL
model	NULL
for	NULL
further	NULL
study	NULL
of	NULL
CD14	NULL
expression	NULL
.	NULL

The	NULL
CD14	NULL
5'-Upstream	NULL
Sequence	NULL
Contains	NULL
Strong	NULL
Tissue-specific	NULL
Promoter	NULL
Activity-To	NULL
analyze	NULL
the	NULL
5'-flanking	NULL
region	NULL
for	NULL
promoter	NULL
activity	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
fragments	NULL
of	NULL
CD14	NULL
5'-upstream	NULL
sequence	NULL
were	NULL
generated	NULL
by	NULL
either	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
or	NULL
PCR	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
luciferase	NULL
reporter	NULL
vector	NULL
pXP2	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
.	NULL

Promoter	NULL
activity	NULL
was	NULL
monitored	NULL
by	NULL
luciferase	NULL
assay	NULL
after	NULL
transfection	NULL
into	NULL
the	NULL
CD14	NULL
expressing	NULL
cell	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
.	NULL

All	NULL
values	NULL
were	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
with	NULL
co-transfection	NULL
of	NULL
RSV-hGH	NULL
.	NULL

In	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
the	NULL
CD14	NULL
5'-flanking	NULL
region	NULL
demonstrated	NULL
very	NULL
strong	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
of	NULL
p-227CD14-lue	NULL
transfection	NULL
was	NULL
over	NULL
300-fold	NULL
higher	NULL
than	NULL
the	NULL
pXP2	NULL
promoterless	NULL
construct	NULL
.	NULL

As	NULL
little	NULL
as	NULL
128	NULL
bp	NULL
of	NULL
upstream	NULL
sequence	NULL
was	NULL
capable	NULL
of	NULL
directing	NULL
reporter	NULL
activity	NULL
120-fold	NULL
above	NULL
pXP2	NULL
.	NULL

Addition	NULL
of	NULL
sequences	NULL
up	NULL
to	NULL
4.2	NULL
kb	NULL
upstream	NULL
did	NULL
not	NULL
yield	NULL
higher	NULL
promoter	NULL
activity	NULL
compared	NULL
to	NULL
the	NULL
bp	NULL
-227	NULL
to	NULL
+80	NULL
construct	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
CD14	NULL
promoter	NULL
directed	NULL
tissue-specific	NULL
reporter	NULL
activity	NULL
,	NULL
CD14	NULL
promoter	NULL
activity	NULL
was	NULL
also	NULL
examined	NULL
in	NULL
the	NULL
CD14	NULL
negative	NULL
cell	NULL
lines	NULL
REX	NULL
and	NULL
HeLa	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
comparative	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
CD14	NULL
promoter	NULL
functions	NULL
18-28-fold	NULL
more	NULL
efficiently	NULL
in	NULL
CD14+	NULL
cells	NULL
than	NULL
in	NULL
CD14-	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
results	NULL
of	NULL
these	NULL
transfection	NULL
experiments	NULL
demonstrated	NULL
that	NULL
as	NULL
little	NULL
as	NULL
128	NULL
bp	NULL
of	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
CD14	NULL
gene	NULL
contains	NULL
strong	NULL
tissue-specific	NULL
promoter	NULL
activity	NULL
.	NULL

Sp1	NULL
Directs	NULL
Monocytic	NULL
Specific	NULL
CD14	NULL
Promoter	NULL
Expression	NULL
DNase	NULL
I	NULL
Footprinting	NULL
Analysis	NULL
Reveals	NULL
Multiple	NULL
Interactions	NULL
between	NULL
Nuclear	NULL
Proteins	NULL
and	NULL
the	NULL
CD14	NULL
Promoter-Important	NULL
cis-acting	NULL
elements	NULL
of	NULL
promoters	NULL
direct	NULL
gene	NULL
expression	NULL
through	NULL
interaction	NULL
with	NULL
tissue-specific	NULL
and	NULL
constitutive	NULL
transacting	NULL
factors	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
was	NULL
used	NULL
to	NULL
study	NULL
the	NULL
interaction	NULL
of	NULL
nuclear	NULL
proteins	NULL
with	NULL
the	NULL
DNA	NULL
fragment	NULL
including	NULL
the	NULL
strong	NULL
bp	NULL
-227	NULL
to	NULL
+80	NULL
tissue-specific	NULL
promoter	NULL
described	NULL
above	NULL
.	NULL

Nuclear	NULL
extracts	NULL
isolated	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
this	NULL
footprinting	NULL
analysis	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
,	NULL
Panels	NULL
A	NULL
and	NULL
B	NULL
,	NULL
show	NULL
the	NULL
footprinting	NULL
results	NULL
with	NULL
coding	NULL
and	NULL
noncoding	NULL
strand	NULL
labeled	NULL
DNA	NULL
fragments	NULL
,	NULL
respectively	NULL
.	NULL

There	NULL
are	NULL
four	NULL
strongly	NULL
protected	NULL
regions	NULL
marked	NULL
with	NULL
bars	NULL
and	NULL
roman	NULL
numerals	NULL
.	NULL

Region	NULL
I	NULL
includes	NULL
the	NULL
TATA	NULL
box	NULL
sequence	NULL
ATAAA	NULL
.	NULL

Region	NULL
II	NULL
contains	NULL
sequences	NULL
similar	NULL
to	NULL
PU.1	NULL
and	NULL
Myb	NULL
binding	NULL
sites	NULL
.	NULL

Region	NULL
III	NULL
includes	NULL
a	NULL
sequence	NULL
similar	NULL
to	NULL
a	NULL
PU.1	NULL
binding	NULL
site	NULL
.	NULL

Region	NULL
IV	NULL
contains	NULL
sequences	NULL
similar	NULL
to	NULL
NF-IL6	NULL
and	NULL
PU.1	NULL
binding	NULL
consensus	NULL
sites	NULL
.	NULL

A	NULL
summary	NULL
of	NULL
the	NULL
specific	NULL
sequences	NULL
protected	NULL
in	NULL
the	NULL
DNase	NULL
I	NULL
footprinting	NULL
experiments	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
.	NULL

Transcription	NULL
Factor	NULL
Sp1	NULL
Binds	NULL
to	NULL
the	NULL
CD14	NULL
Promoter-The	NULL
sequence	NULL
GGGCTGG	NULL
at	NULL
the	NULL
3	NULL
'	NULL
side	NULL
of	NULL
protected	NULL
region	NULL
IV	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
Sp1	NULL
binding	NULL
consensus	NULL
sequence	NULL
GGGCGG	NULL
(	NULL
Dynan	NULL
and	NULL
Tjian	NULL
,	NULL
1983	NULL
;	NULL
Letovsky	NULL
and	NULL
Dynan	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
whether	NULL
Sp1	NULL
can	NULL
interact	NULL
with	NULL
the	NULL
CD14	NULL
promoter	NULL
,	NULL
purified	NULL
Spl	NULL
protein	NULL
was	NULL
used	NULL
in	NULL
a	NULL
DNase	NULL
I	NULL
protection	NULL
experiment	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

There	NULL
was	NULL
a	NULL
strong	NULL
Sp1	NULL
binding	NULL
site	NULL
from	NULL
bp	NULL
-99	NULL
to	NULL
-118	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
and	NULL
two	NULL
weak	NULL
binding	NULL
sites	NULL
(	NULL
bp	NULL
-50	NULL
to	NULL
-70	NULL
and	NULL
bp	NULL
-75	NULL
to	NULL
-94	NULL
)	NULL
.	NULL

The	NULL
strong	NULL
Sp1	NULL
binding	NULL
site	NULL
includes	NULL
the	NULL
GGGCTGG	NULL
sequence	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
purified	NULL
AP-2	NULL
protein	NULL
was	NULL
also	NULL
used	NULL
in	NULL
the	NULL
DNase	NULL
I	NULL
footprinting	NULL
experiments	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
Lane	NULL
3	NULL
.	NULL

No	NULL
interaction	NULL
of	NULL
AP-2	NULL
and	NULL
CD14	NULL
promoter	NULL
fragment	NULL
can	NULL
be	NULL
detected	NULL
.	NULL

To	NULL
verify	NULL
whether	NULL
Sp1	NULL
is	NULL
indeed	NULL
a	NULL
component	NULL
of	NULL
the	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
an	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
CD14	NULL
promoter	NULL
region	NULL
from	NULL
bp	NULL
-124	NULL
to	NULL
96	NULL
was	NULL
used	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
analysis	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
from	NULL
non-monocytic	NULL
HeLa	NULL
and	NULL
REX	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
Lanes	NULL
2-4	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
the	NULL
figure	NULL
,	NULL
there	NULL
were	NULL
no	NULL
tissue-specific	NULL
factors	NULL
interacting	NULL
with	NULL
this	NULL
region	NULL
of	NULL
CD14	NULL
promoter	NULL
.	NULL

The	NULL
major	NULL
shifted	NULL
complex	NULL
(	NULL
labeled	NULL
Sp1	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
can	NULL
be	NULL
competed	NULL
with	NULL
unlabeled	NULL
self	NULL
oligonucleotide	NULL
(	NULL
Lane	NULL
5	NULL
)	NULL
and	NULL
a	NULL
characterized	NULL
Sp1	NULL
binding	NULL
oligonucleotide	NULL
(	NULL
Lane	NULL
6	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
non-Sp1	NULL
binding	NULL
oligonucleotide	NULL
(	NULL
Lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
Spl	NULL
complex	NULL
also	NULL
can	NULL
be	NULL
specifically	NULL
reduced	NULL
with	NULL
Sp1	NULL
antibody	NULL
(	NULL
Lane	NULL
8	NULL
)	NULL
,	NULL
but	NULL
not	NULL
with	NULL
preimmune	NULL
serum	NULL
(	NULL
Lane	NULL
9	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
Spl	NULL
binds	NULL
to	NULL
the	NULL
CD14	NULL
promoter	NULL
in	NULL
nuclear	NULL
extracts	NULL
.	NULL

Two	NULL
complexes	NULL
designated	NULL
with	NULL
astersiks	NULL
(	NULL
*	NULL
)	NULL
are	NULL
shifted	NULL
bands	NULL
likely	NULL
generated	NULL
by	NULL
degraded	NULL
Sp1	NULL
protein	NULL
,	NULL
since	NULL
an	NULL
older	NULL
lot	NULL
of	NULL
purified	NULL
Sp1	NULL
protein	NULL
(	NULL
Promega	NULL
)	NULL
also	NULL
gave	NULL
these	NULL
two	NULL
complexes	NULL
which	NULL
could	NULL
be	NULL
competed	NULL
with	NULL
Sp1	NULL
binding	NULL
oligonucleotides	NULL
but	NULL
not	NULL
abrogated	NULL
by	NULL
Sp1	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
observed	NULL
such	NULL
faster	NULL
migrating	NULL
Spl	NULL
complexes	NULL
using	NULL
monocytic	NULL
nuclear	NULL
extracts	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
Sp1	NULL
Binding	NULL
Site	NULL
Is	NULL
Critical	NULL
for	NULL
the	NULL
Tissue-specific	NULL
Expression	NULL
of	NULL
CD14	NULL
Promoter-To	NULL
verify	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
Sp1	NULL
for	NULL
CD14	NULL
promoter	NULL
activity	NULL
,	NULL
3	NULL
base	NULL
pairs	NULL
(	NULL
-110	NULL
to	NULL
-108	NULL
bp	NULL
)	NULL
in	NULL
the	NULL
core	NULL
Sp1	NULL
binding	NULL
site	NULL
were	NULL
changed	NULL
from	NULL
GGG	NULL
to	NULL
TAC	NULL
by	NULL
PCR	NULL
mediated	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
.	NULL

This	NULL
mutation	NULL
destroyed	NULL
Spl	NULL
binding	NULL
to	NULL
the	NULL
-110-bp	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Luciferase	NULL
constructs	NULL
with	NULL
and	NULL
without	NULL
this	NULL
mutation	NULL
in	NULL
CD14	NULL
promoter	NULL
were	NULL
used	NULL
in	NULL
transient	NULL
transfections	NULL
.	NULL

The	NULL
mutation	NULL
decreased	NULL
relative	NULL
CD14	NULL
promoter	NULL
activity	NULL
10-fold	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
wild	NULL
type	NULL
CD14	NULL
promoter	NULL
is	NULL
much	NULL
more	NULL
active	NULL
in	NULL
the	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
compared	NULL
to	NULL
non-monocytic	NULL
HeLa	NULL
and	NULL
REX	NULL
cells	NULL
,	NULL
the	NULL
Sp1	NULL
binding	NULL
site	NULL
mutation	NULL
has	NULL
a	NULL
much	NULL
stronger	NULL
relative	NULL
effect	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
than	NULL
in	NULL
HeLa	NULL
and	NULL
REX	NULL
cells	NULL
.	NULL

When	NULL
the	NULL
wild	NULL
type	NULL
construct	NULL
p-227CD14-lue	NULL
was	NULL
Sp1	NULL
Directs	NULL
Monocytic	NULL
Specific	NULL
CD14	NULL
Promoter	NULL
Expression	NULL
11429	NULL
MOUSE	NULL
TAAAGAACTGAATAAGATGCCAAGAAGGGAGAATTATTTTTCATATTA	NULL
-	NULL
ACTCTCAACTTTGAGCTTTATTCTCTGCCTGGAATCTATAGATAACTTCACA	NULL
G	NULL
AA	NULL
TAT	NULL
T	NULL
ATATT	NULL
A	NULL
ACTT	NULL
GA	NULL
TGG	NULL
C	NULL
_	NULL
AGAT	NULL
HUMAN	NULL
AGTTAAATATCTGAGGATATTCAGGG	NULL
--	NULL
-ACTTGGATT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
TGGTGGCAGGAGAT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
460*~	NULL
-450*	NULL
-440*	NULL
-430*	NULL
MOUSE	NULL
ATCTTTCCACAAATGTCCAATTACATTCAAAGAAAATCAAGAGCTGGATT	NULL
-	NULL
-	NULL
-	NULL
TCAACGGTGGGAAATTGCTAGCAAC	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
TAAGACTAGGGGA	NULL
CAA	NULL
-	NULL
AAA	NULL
CAAGA	NULL
-	NULL
GGA	NULL
TCAA	NULL
G	NULL
CAA	NULL
TAG	NULL
-	NULL
C	NULL
TAAG	NULL
GGGGA	NULL
HUMAN	NULL
|	NULL
CAACATAAACCAAGACRAGGAAGAAGTCAAAGAAATGAATCAAGTAGATTCTCTGGGATATAAGGTAGGGGGA	NULL
-420*	NULL
-410*	NULL
-400*	NULL
-390*~	NULL
-380	NULL
``	NULL
*	NULL
-370*	NULL
-360*	NULL
-350*	NULL
MOUSE	NULL
AATGGAGGTGAATCA	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
ATGGCACTGCACCAACAGAATAATGATCTAAGGCACT	NULL
-	NULL
AGGTGTGATTCACTCTTITTCCTGTACGCACCAGACAAGT	NULL
A	NULL
ATGG	NULL
ACTG	NULL
CTAAGCCACT	NULL
-	NULL
TCA	NULL
CTTTTCC	NULL
AC	NULL
CACCAGA	NULL
AAG	NULL
HUMAN	NULL
TTGGGGGGTTGGATAGTGCAGAGTATGGTACTGGC	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
CTAAGGCACTGAGGA	NULL
--	NULL
--	NULL
-	NULL
TCATCCTTTTCCCACACCCACCAGAGAAGG	NULL
-340*	NULL
-330*	NULL
-320*	NULL
-~310	NULL
``	NULL
-300*	NULL
-290*	NULL
-280*~	NULL
-270	NULL
``	NULL
MOUSE	NULL
CCGSGGCTCATAGGTCATCCT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
CACAGAATGCCCTA-ATGCCACTCTGAATTCT	NULL
c	NULL
-_	NULL
cecere	NULL
TCA	NULL
C	NULL
[	NULL
elouiele	NULL
}	NULL
CACAGAA	NULL
CCCTA	NULL
ATGCC	NULL
-	NULL
C	NULL
GAAT	NULL
CT	NULL
HUMAN	NULL
CTTAGGCTCCCGAGTCAACAGGGCATTCACGCCTGCGGGCGCCTGAGTCATCAGGACACTGCCAGGACGACACAGAA-	NULL
-	NULL
CCCTAGATGCCCTGCAGAATCCT	NULL
-260*	NULL
-250*	NULL
-240*	NULL
-230*	NULL
-220*	NULL
-210*	NULL
-200*	NULL
-190*	NULL
-180*	NULL
MOUSE	NULL
TCCTGTTTTTCGTCCC-	NULL
TCCCTAAAAAACACTTCCTTGCAATATTTACTAGAAGTGAGTAGGGCTGTTA	NULL
-	NULL
GGAGGAAGAGAAGTGGAGACGCAATTAGAA	NULL
TCCTGTT	NULL
CCC	NULL
TCCCT	NULL
AAA	NULL
A	NULL
CTTC	NULL
TTGCAATATTT	NULL
C	NULL
GAA	NULL
GA	NULL
-	NULL
GGAGGAAGAGA	NULL
GTGG	NULL
GA	NULL
G	NULL
AT	NULL
AG	NULL
HUMAN	NULL
TCCTEGTTACGSTCCCCCTCCCTGAAACATCCTTCATTGCAATATTTCCAGCAAAGGAAGGGGGCTGGCTCGGAGGAAGAGAGCGTGGSGAGGTGATCAGCGG	NULL
-170*~	NULL
-160*	NULL
-150*	NULL
-140*	NULL
-130*	NULL
-120*	NULL
-110*	NULL
-100*	NULL
-90*	NULL
-80*	NULL
¥	NULL
MOUSE	NULL
TTCACAGAGGAAGGGACAGGCTGACACCCCAGGATTACATAAATTTACAGGGGCTGCCGAATTGGTCGAACAAGCCCGTGGAACCTGGAAGCCAGAGAAC	NULL
TTCACAGAGGA	NULL
GG	NULL
AC	NULL
G	NULL
TGACA	NULL
CCCAGGATTACATAAA	NULL
T	NULL
CAG	NULL
GGC	NULL
GCCGAA	NULL
G	NULL
TC	NULL
ACAAG	NULL
-	NULL
GTG	NULL
A	NULL
CCTGGAAGCC	NULL
G	NULL
G	NULL
HUMAN	NULL
TTCACAGAGGAGGGAACTGAATGACATCCCAGGATTACATAAACTGTCAGAGGCAGCCGAAGAGTTC—-ACAAGT—-GTGAAGCCTGGAAGCCGGCGGGT	NULL
-70*	NULL
-60*	NULL
-50*	NULL
-40*	NULL
-30*	NULL
-20*	NULL
-10*	NULL
+11*	NULL
+21	NULL
``	NULL
MOUSE	NULL
ACCATCGCTGTAAAGCAAAGAAACTGAAGCTTTTCTCGGAGCCTATCTGGGCTGCTCAAACTTTCAGAATCTAC-	NULL
-	NULL
CGACCATGGTGAGTCAGACAGACT	NULL
c	NULL
-	NULL
CGCTGT	NULL
AGGAAAGAA	NULL
CT	NULL
AAGC	NULL
TTC	NULL
GAGCCT	NULL
TC	NULL
GG	NULL
GCTCA	NULL
A	NULL
TTC	NULL
GAA	NULL
CGACCATGGTGAGT	NULL
HUMAN	NULL
GC-	NULL
-	NULL
-	NULL
CGCTGTGTAGGAAAGAAGCTAAAGCACTTCCA-GAGCCTGTCCGGA	NULL
-	NULL
-	NULL
GCTCAGAGCGTTCGGAAGACTTATCGACCATGGTGAGTGTAGG-	NULL
-	NULL
-	NULL
-	NULL
+31*	NULL
+41*	NULL
+51*	NULL
+61	NULL
``	NULL
+71	NULL
``	NULL
+81*	NULL
+91*	NULL
+101*	NULL
+111*	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Comparison	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
CD14	NULL
5'-flanking	NULL
regions	NULL
.	NULL

Alignment	NULL
of	NULL
the	NULL
two	NULL
sequences	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
ALIGN	NULL
program	NULL
(	NULL
DNASTAR	NULL
)	NULL
.	NULL

Identities	NULL
between	NULL
human	NULL
and	NULL
murine	NULL
sequences	NULL
are	NULL
indicated	NULL
by	NULL
showing	NULL
the	NULL
base	NULL
in	NULL
between	NULL
the	NULL
two	NULL
lines	NULL
of	NULL
sequences	NULL
;	NULL
nonidentities	NULL
are	NULL
indicated	NULL
by	NULL
not	NULL
showing	NULL
the	NULL
base	NULL
.	NULL

Dashes	NULL
are	NULL
inserted	NULL
for	NULL
optimal	NULL
alignment	NULL
.	NULL

Base	NULL
numbering	NULL
is	NULL
based	NULL
on	NULL
the	NULL
human	NULL
CD14	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
as	NULL
+1	NULL
.	NULL

The	NULL
murine	NULL
transcription	NULL
initiation	NULL
site	NULL
is	NULL
marked	NULL
with	NULL
a	NULL
black	NULL
triangle	NULL
.	NULL

Double	NULL
underline	NULL
indicates	NULL
the	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
responsive	NULL
element-like	NULL
sequence	NULL
(	NULL
TLS	NULL
)	NULL
which	NULL
has	NULL
been	NULL
reported	NULL
as	NULL
the	NULL
critical	NULL
region	NULL
for	NULL
murine	NULL
CD14	NULL
tissue-specific	NULL
expression	NULL
(	NULL
Matsuura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

used	NULL
in	NULL
the	NULL
transfection	NULL
,	NULL
CD14	NULL
promoter	NULL
activity	NULL
was	NULL
15-	NULL
and	NULL
38-fold	NULL
higher	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
compared	NULL
to	NULL
REX	NULL
cells	NULL
and	NULL
Hela	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

When	NULL
the	NULL
Spl	NULL
mutant	NULL
construct	NULL
p-227CD14	NULL
(	NULL
m110	NULL
)	NULL
-lue	NULL
was	NULL
used	NULL
,	NULL
CD14	NULL
promoter	NULL
activity	NULL
was	NULL
only	NULL
3-	NULL
and	NULL
5-fold	NULL
higher	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
compared	NULL
to	NULL
REX	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Sp1	NULL
Can	NULL
Transactivate	NULL
the	NULL
CD14	NULL
Promoter	NULL
in	NULL
Sp1	NULL
Negative	NULL
Drosophila	NULL
Cell	NULL
Lines-To	NULL
further	NULL
demonstrate	NULL
the	NULL
importance	NULL
of	NULL
Spl	NULL
to	NULL
CD14	NULL
promoter	NULL
activity	NULL
,	NULL
Spl	NULL
transactivation	NULL
experiments	NULL
in	NULL
the	NULL
Sp1	NULL
negative	NULL
Drosophila	NULL
Schneider	NULL
S2	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

The	NULL
results	NULL
showed	NULL
no	NULL
transactivation	NULL
of	NULL
the	NULL
promoterless	NULL
pXP2	NULL
and	NULL
herpes	NULL
simplex	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
pT81-luc	NULL
luciferase	NULL
constructs	NULL
.	NULL

When	NULL
an	NULL
Sp1	NULL
binding	NULL
site	NULL
is	NULL
inserted	NULL
into	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
(	NULL
the	NULL
pT109-lue	NULL
construct	NULL
)	NULL
,	NULL
Spl	NULL
can	NULL
transactivate	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
8-fold	NULL
.	NULL

When	NULL
the	NULL
CD14	NULL
promoter	NULL
was	NULL
used	NULL
in	NULL
place	NULL
of	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
,	NULL
Spl	NULL
transactivated	NULL
the	NULL
promoter	NULL
44-fold	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
Spl	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
CD14	NULL
expression	NULL
.	NULL

When	NULL
the	NULL
-110	NULL
bp	NULL
Sp1	NULL
binding	NULL
site-mutated	NULL
CD14	NULL
promoter	NULL
was	NULL
used	NULL
in	NULL
the	NULL
same	NULL
experiments	NULL
,	NULL
Sp1	NULL
still	NULL
could	NULL
trans-activate	NULL
CD14	NULL
promoter	NULL
,	NULL
but	NULL
the	NULL
transactivation	NULL
was	NULL
much	NULL
weaker	NULL
,	NULL
about	NULL
10-fold	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

This	NULL
remaining	NULL
10-fold	NULL
increase	NULL
could	NULL
due	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
other	NULL
Sp1	NULL
binding	NULL
sites	NULL
,	NULL
or	NULL
perhaps	NULL
by	NULL
Spl	NULL
stimulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
other	NULL
CD14	NULL
promoter	NULL
binding	NULL
factors	NULL
.	NULL

Characterization	NULL
of	NULL
Sp1	NULL
in	NULL
Monocytic	NULL
and	NULL
Non-monocytic	NULL
Cells-The	NULL
above	NULL
results	NULL
demonstrate	NULL
that	NULL
Sp1	NULL
is	NULL
an	NULL
important	NULL
transcriptional	NULL
regulator	NULL
of	NULL
CD14	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

We	NULL
asked	NULL
whether	NULL
there	NULL
was	NULL
a	NULL
difference	NULL
in	NULL
affinity	NULL
of	NULL
binding	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
monocytic	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
and	NULL
non-monocytic	NULL
HeLa	NULL
.	NULL

The	NULL
CD14	NULL
Sp1	NULL
binding	NULL
site	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
in	NULL
on-rate	NULL
and	NULL
off-rate	NULL
experiments	NULL
to	NULL
analyze	NULL
the	NULL
association	NULL
and	NULL
dissociation	NULL
rates	NULL
of	NULL
Sp1	NULL
complex	NULL
(	NULL
Wagner	NULL
and	NULL
Green	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
the	NULL
conditions	NULL
used	NULL
to	NULL
perform	NULL
these	NULL
experiments	NULL
,	NULL
there	NULL
were	NULL
no	NULL
significant	NULL
differ	NULL
ences	NULL
in	NULL
Sp1	NULL
binding	NULL
on-	NULL
and	NULL
off-rates	NULL
between	NULL
nuclear	NULL
extracts	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Sp1	NULL
exists	NULL
in	NULL
multiple	NULL
forms	NULL
,	NULL
including	NULL
differences	NULL
in	NULL
glyco-sylation	NULL
and	NULL
phosphorylation	NULL
(	NULL
Jackson	NULL
and	NULL
Tjian	NULL
,	NULL
1988	NULL
;	NULL
Jackson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
which	NULL
can	NULL
be	NULL
distinguished	NULL
by	NULL
SDS-polyacryl1-amide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
Jackson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
different	NULL
forms	NULL
of	NULL
Spl	NULL
interact	NULL
with	NULL
the	NULL
CD14	NULL
Sp1	NULL
site	NULL
in	NULL
different	NULL
cells	NULL
,	NULL
whole	NULL
cell	NULL
protein	NULL
extracts	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
separated	NULL
in	NULL
SDS-polyacrylamide	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
and	NULL
studied	NULL
by	NULL
Southwestern	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
P-CD14	NULL
Spl	NULL
binding	NULL
site	NULL
probe	NULL
was	NULL
used	NULL
in	NULL
the	NULL
hybridization	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

104	NULL
,	NULL
the	NULL
CD14	NULL
Sp1	NULL
site	NULL
probe	NULL
only	NULL
interacted	NULL
with	NULL
the	NULL
105-kDa	NULL
form	NULL
of	NULL
Spl	NULL
(	NULL
con-firmed	NULL
by	NULL
the	NULL
following	NULL
Western	NULL
blot	NULL
analysis	NULL
in	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
and	NULL
there	NULL
was	NULL
no	NULL
cell	NULL
type-specific	NULL
band	NULL
detected	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

To	NULL
study	NULL
which	NULL
Sp1	NULL
forms	NULL
are	NULL
present	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
,	NULL
the	NULL
same	NULL
nitrocellulose	NULL
membrane	NULL
used	NULL
in	NULL
the	NULL
Southwestern	NULL
analysis	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

10A	NULL
was	NULL
washed	NULL
and	NULL
reused	NULL
in	NULL
a	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10B	NULL
,	NULL
polyclonal	NULL
Spl	NULL
antibody	NULL
detected	NULL
a	NULL
DNA	NULL
binding	NULL
105-kDa	NULL
and	NULL
a	NULL
non-DNA	NULL
binding	NULL
95-kDa	NULL
Sp1	NULL
protein	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
slower	NULL
migrating	NULL
form	NULL
which	NULL
has	NULL
also	NULL
been	NULL
observed	NULL
previously	NULL
(	NULL
Jackson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Katai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
had	NULL
65	NULL
%	NULL
less	NULL
total	NULL
Sp1	NULL
than	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
105-kDa	NULL
Sp1	NULL
to	NULL
95-kDa	NULL
Sp1	NULL
is	NULL
higher	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
(	NULL
1:2	NULL
)	NULL
than	NULL
the	NULL
ratio	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
1:4	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
report	NULL
the	NULL
isolation	NULL
of	NULL
the	NULL
promoter	NULL
for	NULL
the	NULL
human	NULL
monocytic	NULL
differentiation	NULL
antigen	NULL
CD14	NULL
,	NULL
which	NULL
provides	NULL
an	NULL
opportunity	NULL
to	NULL
study	NULL
the	NULL
regulation	NULL
of	NULL
tissue	NULL
and	NULL
differentiation	NULL
specific	NULL
CD14	NULL
expression	NULL
through	NULL
analysis	NULL
of	NULL
the	NULL
cis-acting	NULL
promoter	NULL
elements	NULL
and	NULL
identification	NULL
of	NULL
the	NULL
important	NULL
trans-acting	NULL
factors	NULL
interacting	NULL
with	NULL
these	NULL
elements	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
our	NULL
studies	NULL
with	NULL
the	NULL
human	NULL
CD14	NULL
pro	NULL
11430	NULL
Sp1	NULL
Directs	NULL
Monocytic	NULL
Specific	NULL
CD14	NULL
Promoter	NULL
Expression	NULL
A	NULL
He	NULL
Mo	NULL
®	NULL
=-	NULL
28	NULL
8	NULL
-	NULL
188	NULL
28	NULL
S	NULL
RNA	NULL
®	NULL
-4.2k	NULL
Tae	NULL
p-4.2kCD14-lue	NULL
-2.8k	NULL
Luc	NULL
p-2.8kCD14-luc	NULL
-2.3k	NULL
Luc	NULL
p-2.3kCD14-lue	NULL
-449	NULL
Luc	NULL
p-449CD14-luc	NULL
+227	NULL
Luc	NULL
p-227CD14-luc	NULL
+128	NULL
-|	NULL
Luc	NULL
p-128CD14-luc	NULL
Luc	NULL
pXP2	NULL
I	NULL
U	NULL
T	NULL
U	NULL
I	NULL
U	NULL
0	NULL
2	NULL
0	NULL
4	NULL
0	NULL
6	NULL
0	NULL
8	NULL
0	NULL
100	NULL
120	NULL
Relative	NULL
Promoter	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
rr	NULL
O	NULL
j	NULL
&	NULL
OIJ	NULL
+	NULL
p-2.8kCD14-lue	NULL
B	NULL
227	NULL
+80	NULL
p-227CD14-lue	NULL
le	NULL
]	NULL
c	NULL
+	NULL
C	NULL
128	NULL
pxp2	NULL
``	NULL
y-	NULL
T	NULL
T	NULL
T	NULL
T	NULL
U	NULL
0	NULL
10000	NULL
20000	NULL
30000	NULL
40000	NULL
50000	NULL
60000	NULL
70000	NULL
Promoter	NULL
Activity	NULL
(	NULL
Relative	NULL
Light	NULL
Units/ng	NULL
Growth	NULL
Hormone	NULL
)	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
human	NULL
CD14	NULL
promoter	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
CD14	NULL
mRNA	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
untreated	NULL
HeLa	NULL
cells	NULL
(	NULL
He	NULL
)	NULL
and	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
(	NULL
Mo	NULL
)	NULL
.	NULL

Twenty-five	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
loaded	NULL
on	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
sequentially	NULL
hybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
CD14	NULL
cDNA	NULL
and	NULL
a	NULL
28	NULL
S	NULL
rRNA-specific	NULL
oligonucleotide	NULL
probe	NULL
to	NULL
control	NULL
for	NULL
equivalent	NULL
RNA	NULL
loading	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
.	NULL

Schematic	NULL
representations	NULL
of	NULL
the	NULL
CD14	NULL
promoter-luciferase	NULL
constructs	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

These	NULL
constructs	NULL
as	NULL
well	NULL
as	NULL
the	NULL
promoterless	NULL
pXP2	NULL
vector	NULL
alone	NULL
were	NULL
transfected	NULL
into	NULL
CD14	NULL
expressing	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
corrected	NULL
by	NULL
co-transfecting	NULL
RSV-hGH	NULL
.	NULL

One-fifth	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
luminescence	NULL
5	NULL
h	NULL
later	NULL
.	NULL

Relative	NULL
light	NULL
units	NULL
were	NULL
corrected	NULL
based	NULL
on	NULL
Sp1	NULL
Directs	NULL
Monocytic	NULL
Specific	NULL
CD14	NULL
Promoter	NULL
Expression	NULL
11431	NULL
HeLa	NULL
Mono	NULL
HeLa	NULL
Mono	NULL
7	NULL
,	NULL
0	NULL
50	NULL
100	NULL
50	NULL
100	NULL
I	NULL
©	NULL
!	NULL

_	NULL
0	NULL
50	NULL
100	NULL
50	NULL
100	NULL
tH	NULL
#	NULL
80	NULL
H	NULL
$	NULL
#	NULL
#	NULL
4	NULL
|	NULL
uma	NULL
abn	NULL
e	NULL
~174	NULL
©	NULL
ome	NULL
#	NULL
8	NULL
#	NULL
+	NULL
a	NULL
u	NULL
aa	NULL
{	NULL
+=	NULL
sine	NULL
we	NULL
;	NULL
.	NULL

nne	NULL
L	NULL
I	NULL
I	NULL
I	NULL
C	NULL
I	NULL
V	NULL
CACAGAACCCTAGATGCCCTGCAGAATCCTTCCTGTTACGGTCCCCCTCCCTGAAACATCCTTCATTGCAATATTTCCAGGAAAGGAAGGGGGCTGGCTC	NULL
-101	NULL
GTGTCTTGGGATCTACGGGACGTCTTAGGAAGGACAATGCCAGGGGGAGGGACTTTGTAGGAAGTAACGTTATAAAGGTCCTTTCCTTCCCCCGACCGAG	NULL
001	NULL
I	NULL
I	NULL
I	NULL
Spi	NULL
GGAGGAAGAGAGGTGGGGAGGTGATCAGGGTTCACAGAGGAGGGAACTGAATGACATCCCAGGATTACATAAACTGTCAGAGGCAGCCGAAGAGTTCACA	NULL
-1	NULL
CCTCCTTCTCTCCACCCCTCCACTAGTCCCAAGTGTCTCCTCCCTTGACTTACTGTAGGGTCCTAATGTATTTGACAGTCTCCGTCGGCAACTCAAGTGT	NULL
Spi	NULL
$	NULL
pi	NULL
AGTGTGAAGCCTGGAAGCCGGCGGGTGCCGCTGTGTAGGAAAGAAGCTAAAGCACTTCCAGAGCCTGTCCGGAGCTCAGAGGTTCGGAAGACTTATCGAC	NULL
+100	NULL
TCACACTTCGGACCTTCGGCCGCCCACGGCGACACATCCTTTCTTCGATTTCGTGAAGGTCTCGGACAGGCCTCGAGTCTCCAAGCCTTCTGAATAGCTG	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
of	NULL
the	NULL
human	NULL
CD14	NULL
promoter	NULL
by	NULL
nuclear	NULL
proteins	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
the	NULL
coding	NULL
strand	NULL
labeled	NULL
CD14	NULL
promoter	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
the	NULL
noncoding	NULL
strand	NULL
labeled	NULL
CD14	NULL
promoter	NULL
.	NULL

DNA	NULL
fragments	NULL
were	NULL
incubated	NULL
with	NULL
0	NULL
,	NULL
50	NULL
,	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
as	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
ug	NULL
of	NULL
double	NULL
stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Lane	NULL
G/A	NULL
is	NULL
a	NULL
marker	NULL
consisting	NULL
of	NULL
the	NULL
probe	NULL
DNAs	NULL
subjected	NULL
to	NULL
guanosine	NULL
+	NULL
adenine-specific	NULL
Maxam-Gilbert	NULL
cleavage	NULL
.	NULL

Numbers	NULL
at	NULL
the	NULL
left	NULL
side	NULL
of	NULL
each	NULL
panel	NULL
indicate	NULL
the	NULL
nucleotides	NULL
upstream	NULL
(	NULL
-	NULL
)	NULL
or	NULL
downstream	NULL
(	NULL
+	NULL
)	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
+1	NULL
)	NULL
.	NULL

Sequences	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
are	NULL
indicated	NULL
by	NULL
black	NULL
bars	NULL
and	NULL
the	NULL
roman	NULL
numerals	NULL
refer	NULL
to	NULL
the	NULL
entire	NULL
protected	NULL
region	NULL
.	NULL

Panel	NULL
C	NULL
,	NULL
summary	NULL
of	NULL
the	NULL
protected	NULL
regions	NULL
.	NULL

Protected	NULL
regions	NULL
from	NULL
the	NULL
labeled	NULL
coding	NULL
strand	NULL
and	NULL
noncoding	NULL
strand	NULL
are	NULL
indicated	NULL
by	NULL
lines	NULL
above	NULL
and	NULL
under	NULL
the	NULL
DNA	NULL
sequence	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
dashed	NULL
underlines	NULL
indicate	NULL
the	NULL
regions	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
by	NULL
purified	NULL
Sp1	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6.	NULL
moter	NULL
demonstrate	NULL
that	NULL
a	NULL
fragment	NULL
extending	NULL
from	NULL
bp	NULL
-128	NULL
to	NULL
_	NULL
tion	NULL
start	NULL
site	NULL
reveal	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
several	NULL
factors	NULL
+80	NULL
shows	NULL
strong	NULL
tissue	NULL
specificity	NULL
in	NULL
CD14	NULL
positive	NULL
monocytic	NULL
-	NULL
which	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
monocytic	NULL
specific	NULL
expression	NULL
.	NULL

PU.1	NULL
is	NULL
cells	NULL
compared	NULL
to	NULL
CD14	NULL
negative	NULL
cells	NULL
.	NULL

Functional	NULL
analysis	NULL
with	NULL
a	NULL
monocytic	NULL
and	NULL
B	NULL
cell-specific	NULL
ets	NULL
family	NULL
member	NULL
.	NULL

We	NULL
have	NULL
a	NULL
series	NULL
of	NULL
5'-sequence	NULL
deletion	NULL
mutants	NULL
from	NULL
-4.2	NULL
kb	NULL
indicated	NULL
-	NULL
previously	NULL
demonstrated	NULL
that	NULL
PU.1	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
that	NULL
the	NULL
bp	NULL
-227	NULL
to	NULL
+80	NULL
fragment	NULL
demonstrated	NULL
the	NULL
highest	NULL
-	NULL
monocytic	NULL
specific	NULL
expression	NULL
of	NULL
the	NULL
M-CSF	NULL
receptor	NULL
monocytic	NULL
promoter	NULL
activity	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
important	NULL
cis-acting	NULL
ele-	NULL
promoter	NULL
and	NULL
myeloid-specific	NULL
CD11b	NULL
promoter	NULL
(	NULL
Pahl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
ments	NULL
are	NULL
within	NULL
this	NULL
region	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
still	NULL
possible	NULL
that	NULL
-	NULL
1993	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
a	NULL
potential	NULL
PU.1	NULL
binding	NULL
some	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
elements	NULL
are	NULL
located	NULL
-	NULL
site	NULL
was	NULL
identified	NULL
within	NULL
this	NULL
227-bp	NULL
promoter	NULL
region	NULL
.	NULL

How-between	NULL
-4.2	NULL
kb	NULL
and	NULL
-227	NULL
bp	NULL
.	NULL

ever	NULL
,	NULL
DNase	NULL
I	NULL
footprinting	NULL
and	NULL
gel	NULL
mobility	NULL
shift	NULL
experiments	NULL
Sequence	NULL
analysis	NULL
of	NULL
the	NULL
227	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcrip-	NULL
-	NULL
with	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
protein	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
inter	NULL
the	NULL
amount	NULL
of	NULL
growth	NULL
hormone	NULL
released	NULL
into	NULL
the	NULL
culture	NULL
medium	NULL
for	NULL
each	NULL
transfection	NULL
(	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
presented	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
-227-bp	NULL
construct	NULL
p-227CD14-luc	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
error	NULL
bars	NULL
.	NULL

Panel	NULL
C	NULL
,	NULL
tissue	NULL
specificity	NULL
analysis	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
.	NULL

Schematic	NULL
representations	NULL
of	NULL
the	NULL
CD14	NULL
promoter-luciferase	NULL
constructs	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

These	NULL
constructs	NULL
as	NULL
well	NULL
as	NULL
the	NULL
promoterless	NULL
pXP2	NULL
vector	NULL
alone	NULL
were	NULL
transfected	NULL
into	NULL
CD14	NULL
expressing	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
CD14	NULL
negative	NULL
HeLa	NULL
and	NULL
REX	NULL
cells	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
corrected	NULL
by	NULL
co-transfecting	NULL
RSV-hGH	NULL
.	NULL

One-fifth	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
luminescence	NULL
5	NULL
h	NULL
later	NULL
.	NULL

Relative	NULL
light	NULL
units	NULL
were	NULL
corrected	NULL
based	NULL
on	NULL
the	NULL
amount	NULL
of	NULL
growth	NULL
hormone	NULL
released	NULL
into	NULL
the	NULL
culture	NULL
medium	NULL
for	NULL
each	NULL
transfection	NULL
(	NULL
ng/ml	NULL
)	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
error	NULL
bars	NULL
.	NULL

11432	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
of	NULL
the	NULL
human	NULL
CD14	NULL
promoter	NULL
by	NULL
nuclear	NULL
protein	NULL
Spl	NULL
.	NULL

The	NULL
noncoding	NULL
strand	NULL
labeled	NULL
CD14	NULL
promoter	NULL
DNA	NULL
fragment	NULL
was	NULL
incubated	NULL
with	NULL
no	NULL
protein	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
,	NULL
1	NULL
footprinting	NULL
unit	NULL
of	NULL
purified	NULL
AP-2	NULL
(	NULL
Promega	NULL
)	NULL
(	NULL
Lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
1	NULL
footprinting	NULL
unit	NULL
of	NULL
purified	NULL
Sp1	NULL
(	NULL
Promega	NULL
)	NULL
(	NULL
Lane	NULL
4	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
is	NULL
the	NULL
probe	NULL
DNA	NULL
subjected	NULL
to	NULL
guanosine	NULL
+	NULL
adenine-specific	NULL
Maxam-Gilbert	NULL
cleavage	NULL
.	NULL

Numbers	NULL
at	NULL
the	NULL
left	NULL
side	NULL
of	NULL
the	NULL
panel	NULL
indicate	NULL
the	NULL
nucleotides	NULL
upstream	NULL
(	NULL
-	NULL
)	NULL
or	NULL
downstream	NULL
(	NULL
+	NULL
)	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
+1	NULL
)	NULL
.	NULL

Sequences	NULL
specifically	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
brackets	NULL
.	NULL

action	NULL
within	NULL
bp	NULL
-227	NULL
to	NULL
+80	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

If	NULL
this	NULL
monocytic	NULL
specific	NULL
factor	NULL
plays	NULL
any	NULL
significant	NULL
role	NULL
in	NULL
CD14	NULL
expression	NULL
,	NULL
it	NULL
may	NULL
be	NULL
through	NULL
an	NULL
interaction	NULL
with	NULL
presently	NULL
unidentified	NULL
CD14	NULL
enhancer	NULL
element	NULL
(	NULL
s	NULL
)	NULL
,	NULL
as	NULL
in	NULL
the	NULL
interaction	NULL
of	NULL
PU.1	NULL
with	NULL
the	NULL
immunoglobulin	NULL
x	NULL
chain	NULL
3'-en-hancer	NULL
(	NULL
Pongubala	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
Matsuura	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
presented	NULL
evidence	NULL
for	NULL
the	NULL
existence	NULL
of	NULL
an	NULL
element	NULL
in	NULL
the	NULL
murine	NULL
CD14	NULL
promoter	NULL
which	NULL
was	NULL
capable	NULL
of	NULL
forming	NULL
gel	NULL
shift	NULL
complexes	NULL
with	NULL
proteins	NULL
from	NULL
macrophage	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
promoters	NULL
have	NULL
significant	NULL
similarities	NULL
in	NULL
structure	NULL
,	NULL
with	NULL
a	NULL
nearly	NULL
identical	NULL
transcription	NULL
start	NULL
site	NULL
and	NULL
high	NULL
conservation	NULL
of	NULL
the	NULL
first	NULL
200	NULL
bp	NULL
of	NULL
DNA	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
there	NULL
clearly	NULL
are	NULL
significant	NULL
differences	NULL
in	NULL
the	NULL
regions	NULL
of	NULL
the	NULL
promoters	NULL
which	NULL
direct	NULL
tissue-specific	NULL
promoter	NULL
activity	NULL
.	NULL

Specifically	NULL
,	NULL
we	NULL
have	NULL
found	NULL
no	NULL
evidence	NULL
that	NULL
the	NULL
element	NULL
described	NULL
by	NULL
Matsuura	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
plays	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
human	NULL
CD14	NULL
tissue-specific	NULL
promoter	NULL
activity	NULL
,	NULL
since	NULL
the	NULL
murine	NULL
macrophage	NULL
factor	NULL
binding	NULL
element	NULL
that	NULL
they	NULL
described	NULL
is	NULL
not	NULL
conserved	NULL
with	NULL
the	NULL
human	NULL
promoter	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
and	NULL
the	NULL
corresponding	NULL
region	NULL
of	NULL
the	NULL
human	NULL
promoter	NULL
(	NULL
located	NULL
at	NULL
approximately	NULL
bp	NULL
-295	NULL
)	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
promoter	NULL
activity	NULL
and	NULL
tissue-specific	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
sequence	NULL
GCATTCA	NULL
at	NULL
bp	NULL
-246	NULL
to	NULL
-240	NULL
of	NULL
human	NULL
CD14	NULL
is	NULL
similar	NULL
to	NULL
TGATTCA	NULL
of	NULL
the	NULL
critical	NULL
element	NULL
identified	NULL
by	NULL
Matsuura	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
these	NULL
human	NULL
sequences	NULL
bind	NULL
the	NULL
factor	NULL
reported	NULL
by	NULL
Matsuura	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

We	NULL
provide	NULL
evidence	NULL
for	NULL
a	NULL
role	NULL
for	NULL
Sp1	NULL
in	NULL
the	NULL
tissue	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
.	NULL

While	NULL
Sp1	NULL
is	NULL
expressed	NULL
ubiqui-	NULL
Sp1	NULL
Directs	NULL
Monocytic	NULL
Specific	NULL
CD14	NULL
Promoter	NULL
Expression	NULL
Antibody	NULL
:	NULL
|	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
>	NULL
Competitor	NULL
:	NULL
_	NULL
-	NULL
-	NULL
Protein	NULL
:	NULL
-	NULL
HR	NULL
M	NULL
Lane	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Identification	NULL
of	NULL
Spl	NULL
binding	NULL
to	NULL
the	NULL
CD14	NULL
promoter	NULL
by	NULL
gel	NULL
mobility	NULL
shift	NULL
analysis	NULL
.	NULL

The	NULL
double	NULL
stranded	NULL
CD14	NULL
promoter	NULL
bp	NULL
-124	NULL
to	NULL
-96	NULL
oligonucleotide	NULL
(	NULL
5'-CCAGGAAAGGAAGGGGGCTG-GCTCGGAGG-3	NULL
'	NULL
)	NULL
was	NULL
*P-labeled	NULL
and	NULL
incubated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
double	NULL
stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Lane	NULL
1	NULL
)	NULL
and	NULL
presence	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
prepared	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
,	NULL
REX	NULL
cells	NULL
(	NULL
Lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
Mono-Mac	NULL
6	NULL
cells	NULL
(	NULL
Lanes	NULL
4-9	NULL
)	NULL
.	NULL

The	NULL
following	NULL
unlabeled	NULL
double	NULL
stranded	NULL
competitor	NULL
oligos	NULL
were	NULL
added	NULL
at	NULL
100-fold	NULL
molar	NULL
excess	NULL
over	NULL
probe	NULL
oligo	NULL
:	NULL
Lane	NULL
5	NULL
,	NULL
CD14	NULL
bp	NULL
-124	NULL
to	NULL
-96	NULL
(	NULL
self	NULL
)	NULL
;	NULL
Lane	NULL
6	NULL
,	NULL
oligonucleotide	NULL
5'-AGAAACCCCGCCCACACCTCTGGCCCCACCCCTTCTTCA-3	NULL
'	NULL
from	NULL
the	NULL
tissue	NULL
plasminogen	NULL
activator	NULL
promoter	NULL
,	NULL
which	NULL
contains	NULL
two	NULL
Sp1	NULL
binding	NULL
sites	NULL
(	NULL
Darrow	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
)	NULL
;	NULL
Lane	NULL
7	NULL
,	NULL
oligonucleotide	NULL
5'-GCT-CAAAAGAAGGGCAGAAAAGGAGAAGTAG-3	NULL
'	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
human	NULL
CD11b	NULL
PU.1	NULL
binding	NULL
site	NULL
,	NULL
and	NULL
does	NULL
not	NULL
contain	NULL
any	NULL
Spl	NULL
binding	NULL
site	NULL
(	NULL
Pah	NULL
]	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
Lanes	NULL
8	NULL
and	NULL
9	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
to	NULL
Spl	NULL
(	NULL
Lane	NULL
8	NULL
)	NULL
or	NULL
preimmune	NULL
serum	NULL
(	NULL
Lane	NULL
9	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
free	NULL
probe	NULL
(	NULL
F	NULL
)	NULL
and	NULL
the	NULL
top	NULL
of	NULL
the	NULL
gel	NULL
(	NULL
T	NULL
)	NULL
are	NULL
marked	NULL
on	NULL
the	NULL
right	NULL
side	NULL
of	NULL
the	NULL
panel	NULL
.	NULL

``	NULL
Sp1I	NULL
``	NULL
points	NULL
to	NULL
the	NULL
complex	NULL
formed	NULL
with	NULL
oligonucleotide	NULL
and	NULL
full-length	NULL
Sp1	NULL
.	NULL

Asterisks	NULL
(	NULL
*	NULL
)	NULL
mark	NULL
the	NULL
complexes	NULL
formed	NULL
between	NULL
the	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
degraded	NULL
Sp1	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

7.8	NULL
9	NULL
Probe	NULL
:	NULL
Wild	NULL
Type	NULL
Mutant	NULL
Competitor	NULL
:	NULL
-o	NULL
-	NULL
W	NULL
Mo	NULL
.	NULL

-	NULL
w	NULL
M	NULL
Protein	NULL
:	NULL
~	NULL
+	NULL
+o	NULL
+o	NULL
#	NULL
--	NULL
-+	NULL
Lane	NULL
:	NULL
_	NULL
1	NULL
20	NULL
3	NULL
4	NULL
5	NULL
60	NULL
708	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Competition	NULL
analysis	NULL
of	NULL
the	NULL
Spl	NULL
mutation	NULL
using	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
double	NULL
stranded	NULL
wild	NULL
type	NULL
and	NULL
mutant	NULL
CD14	NULL
promoter	NULL
bp	NULL
-124	NULL
to	NULL
-96	NULL
oligonucleotides	NULL
were	NULL
P-labeled	NULL
and	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Lanes	NULL
1-5	NULL
)	NULL
and	NULL
presence	NULL
(	NULL
Lanes	NULL
2-4	NULL
and	NULL
6-8	NULL
)	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
double	NULL
stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

One	NULL
hundred-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild	NULL
type	NULL
(	NULL
Lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
and	NULL
CD14	NULL
promoter	NULL
Spl	NULL
site	NULL
mutant	NULL
(	NULL
Lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

All	NULL
the	NULL
other	NULL
symbols	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

7.	NULL
tously	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
examined	NULL
,	NULL
its	NULL
expression	NULL
is	NULL
highly	NULL
regulated	NULL
in	NULL
different	NULL
tissues	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
Spl	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
tissues	NULL
,	NULL
suggesting	NULL
an	NULL
important	NULL
role	NULL
in	NULL
hematopoietic	NULL
cell	NULL
development	NULL
(	NULL
Saffer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
erythroid-	NULL
(	NULL
Yu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Gumucio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Jane	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
lymphocyte-specific	NULL
genes	NULL
(	NULL
Spano-poulou	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Studies	NULL
have	NULL
demonstrated	NULL
modulation	NULL
of	NULL
Spl	NULL
activity	NULL
by	NULL
level	NULL
of	NULL
expression	NULL
(	NULL
Saffer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
binding	NULL
affinity	NULL
(	NULL
Borellini	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
post-translational	NULL
modifications	NULL
,	NULL
including	NULL
phosphorylation	NULL
and	NULL
differential	NULL
glycosyla-tion	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
Schaufele	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Jackson	NULL
and	NULL
Sp1	NULL
Directs	NULL
Monocytic	NULL
Specific	NULL
CD14	NULL
Promoter	NULL
Expression	NULL
pXP2	NULL
p-227CD14-luc	NULL
p-227CD14	NULL
(	NULL
m110	NULL
)	NULL
-lue	NULL
pT8i-luc	NULL
pT109-luc	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
10	NULL
20	NULL
3	NULL
0	NULL
4	NULL
0	NULL
5	NULL
0	NULL
6	NULL
¢	NULL
Sp1	NULL
Induction	NULL
of	NULL
Promoter	NULL
Activity	NULL
(	NULL
Fold	NULL
Increase	NULL
)	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Spl	NULL
stimulates	NULL
transcription	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
in	NULL
transactivation	NULL
assays	NULL
.	NULL

Spl	NULL
negative	NULL
Drosophila	NULL
Schneider	NULL
S2	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
Ca	NULL
,	NULL
(	NULL
PO	NULL
,	NULL
)	NULL
,	NULL
precipitation	NULL
method	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
promoterless	NULL
luciferase	NULL
construct	NULL
pXP2	NULL
,	NULL
CD14	NULL
promoter	NULL
construct	NULL
p-227CD14-luec	NULL
,	NULL
bp	NULL
-110	NULL
to	NULL
-108	NULL
Spl	NULL
site	NULL
mutated	NULL
construct	NULL
p-227CD14	NULL
(	NULL
m110	NULL
)	NULL
-luc	NULL
,	NULL
herpes	NULL
simplex	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
construct	NULL
pT81-lue	NULL
(	NULL
which	NULL
does	NULL
not	NULL
contain	NULL
an	NULL
Sp1	NULL
binding	NULL
site	NULL
;	NULL
Nordeen	NULL
(	NULL
1988	NULL
)	NULL
)	NULL
,	NULL
and	NULL
herpes	NULL
simplex	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
construct	NULL
pT109-lue	NULL
(	NULL
which	NULL
contains	NULL
one	NULL
Sp1	NULL
binding	NULL
site	NULL
;	NULL
Nordeen	NULL
(	NULL
1988	NULL
)	NULL
)	NULL
as	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
side	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
co-transfected	NULL
with	NULL
or	NULL
without	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
Spl	NULL
expression	NULL
vector	NULL
pPacSpl	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Spl	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
represents	NULL
the	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
co-transfected	NULL
Sp1	NULL
divided	NULL
by	NULL
that	NULL
obtained	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Spl	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

The	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
error	NULL
bars	NULL
.	NULL

A	NULL
B	NULL
HeMo	NULL
HeMo	NULL
106	NULL
kDa	NULL
80	NULL
kDa	NULL
1	NULL
%	NULL
-	NULL
1	NULL
%	NULL
Fic	NULL
.	NULL

10	NULL
.	NULL

Biochemical	NULL
characterization	NULL
of	NULL
forms	NULL
of	NULL
Spl	NULL
binding	NULL
to	NULL
the	NULL
CD14	NULL
promoter	NULL
site	NULL
oligonucleotide	NULL
.	NULL

Whole	NULL
cell	NULL
proteins	NULL
from	NULL
1.5	NULL
x	NULL
10°	NULL
HeLa	NULL
(	NULL
Lane	NULL
1	NULL
)	NULL
or	NULL
Mono	NULL
Mac	NULL
6	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
6.5	NULL
%	NULL
SDS-polyacrylamide	NULL
(	NULL
bisacrylamide	NULL
:	NULL
acrylamide	NULL
=	NULL
1:29	NULL
)	NULL
gel	NULL
with	NULL
molecular	NULL
weight	NULL
markers	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
P-labeled	NULL
CD14	NULL
promoter	NULL
major	NULL
Spl	NULL
binding	NULL
site	NULL
bp	NULL
-124	NULL
to	NULL
-96	NULL
oligonucleotide	NULL
(	NULL
5'-CCAG-GAAAGGAAGGGGGCTGGCTCGGAGG-3	NULL
'	NULL
)	NULL
in	NULL
Southwestern	NULL
analysis	NULL
(	NULL
Panel	NULL
A	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
blocking	NULL
buffer	NULL
at	NULL
37	NULL
°C	NULL
to	NULL
dissociate	NULL
the	NULL
DNA	NULL
probe	NULL
,	NULL
proteins	NULL
fixed	NULL
to	NULL
the	NULL
nitrocellulose	NULL
membrane	NULL
were	NULL
hybridized	NULL
with	NULL
Sp1	NULL
polyclonal	NULL
antibody	NULL
in	NULL
Western	NULL
blot	NULL
analysis	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
(	NULL
Panel	NULL
B	NULL
)	NULL
.	NULL

Solid	NULL
arrow	NULL
designates	NULL
the	NULL
105-kDa	NULL
Spl	NULL
form	NULL
.	NULL

Dashed	NULL
arrow	NULL
points	NULL
to	NULL
the	NULL
95-kDa	NULL
Sp1	NULL
.	NULL

Tjian	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

Methylation	NULL
of	NULL
Spl	NULL
binding	NULL
sites	NULL
may	NULL
regulate	NULL
developmental	NULL
specificity	NULL
of	NULL
the	NULL
human	NULL
y	NULL
globin	NULL
gene	NULL
promoter	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
Jane	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
Spl	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
retinoic	NULL
acid-induced	NULL
expression	NULL
of	NULL
the	NULL
tissue	NULL
plasminogen	NULL
activator	NULL
gene	NULL
,	NULL
and	NULL
retinoic	NULL
acid	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cell	NULL
lines	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
(	NULL
RB	NULL
)	NULL
can	NULL
activate	NULL
several	NULL
promoters	NULL
through	NULL
a	NULL
response	NULL
element	NULL
consisting	NULL
of	NULL
an	NULL
11433	NULL
Spl	NULL
binding	NULL
site	NULL
(	NULL
Kim	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Udvadia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

RB	NULL
becomes	NULL
dephosphorylated	NULL
(	NULL
and	NULL
therefore	NULL
activated	NULL
)	NULL
during	NULL
the	NULL
course	NULL
of	NULL
myeloid	NULL
differentiation	NULL
of	NULL
promonoblasts	NULL
to	NULL
mono-cytes	NULL
,	NULL
in	NULL
temporal	NULL
association	NULL
with	NULL
the	NULL
up-regulation	NULL
of	NULL
CD14	NULL
mRNA	NULL
expression	NULL
.	NULL

Sp1	NULL
binding	NULL
sites	NULL
,	NULL
present	NULL
in	NULL
multiple	NULL
monocytic	NULL
specific	NULL
genes	NULL
such	NULL
as	NULL
CD11b	NULL
(	NULL
Pahl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
the	NULL
M-CSF	NULL
receptor	NULL
promoter	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
and	NULL
CD14	NULL
,	NULL
could	NULL
facilitate	NULL
the	NULL
modulation	NULL
of	NULL
monocyte	NULL
gene	NULL
expression	NULL
by	NULL
RB	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
Spl	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
monocytic	NULL
specificity	NULL
of	NULL
the	NULL
CD11b	NULL
promoter	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
CD11b	NULL
promoter	NULL
specifically	NULL
in	NULL
myeloid	NULL
cells	NULL
in	NULL
vivo	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
Spl	NULL
may	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
tissue-specific	NULL
promoter	NULL
activity	NULL
of	NULL
monocyte	NULL
genes	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
Spl	NULL
binding	NULL
to	NULL
the	NULL
CD14	NULL
promoter	NULL
with	NULL
DNase	NULL
I	NULL
footprinting	NULL
and	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
CD11b	NULL
Sp1	NULL
site	NULL
,	NULL
in	NULL
which	NULL
mutation	NULL
of	NULL
the	NULL
Sp1	NULL
site	NULL
decreases	NULL
promoter	NULL
activity	NULL
indistinguishably	NULL
in	NULL
both	NULL
monocytic	NULL
and	NULL
non-monocytic	NULL
cells	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
-110	NULL
bp	NULL
Sp1	NULL
binding	NULL
site	NULL
in	NULL
CD14	NULL
promoter	NULL
not	NULL
only	NULL
decreases	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
tissue-specific	NULL
-227	NULL
CD14	NULL
promoter	NULL
10-fold	NULL
,	NULL
but	NULL
also	NULL
results	NULL
in	NULL
a	NULL
relative	NULL
loss	NULL
of	NULL
tissue	NULL
specificity	NULL
,	NULL
in	NULL
that	NULL
the	NULL
mutation	NULL
reduces	NULL
the	NULL
ratio	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
between	NULL
monocytic	NULL
cells	NULL
and	NULL
cervical	NULL
carcinoma	NULL
cells	NULL
from	NULL
40:1	NULL
to	NULL
5:1	NULL
.	NULL

This	NULL
same	NULL
Spl	NULL
site	NULL
mediates	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
;	NULL
-induced	NULL
up-regulation	NULL
of	NULL
CD14	NULL
expression	NULL
when	NULL
monocytic	NULL
cell	NULL
lines	NULL
undergo	NULL
monocytic	NULL
differentiation	NULL
in	NULL
response	NULL
to	NULL
vitamin	NULL
D	NULL
;	NULL
,	NULL
``	NULL
The	NULL
N-terminal	NULL
glutamine-rich	NULL
region	NULL
of	NULL
Spl	NULL
contains	NULL
two	NULL
potent	NULL
transcriptional	NULL
activation	NULL
domains	NULL
(	NULL
Courey	NULL
and	NULL
Tjian	NULL
,	NULL
1988	NULL
)	NULL
and	NULL
is	NULL
important	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
Spl	NULL
homomultimers	NULL
and	NULL
interactions	NULL
with	NULL
the	NULL
transcriptional	NULL
coactivator	NULL
TAF110	NULL
(	NULL
Pascal	NULL
and	NULL
Tjian	NULL
,	NULL
1991	NULL
;	NULL
Hoey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

While	NULL
dephosphorylated	NULL
Sp1	NULL
has	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
95	NULL
kDa	NULL
,	NULL
phosphorylation	NULL
of	NULL
this	NULL
N-terminal	NULL
region	NULL
results	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
105-kDa	NULL
form	NULL
(	NULL
Jackson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
ratios	NULL
of	NULL
105-	NULL
and	NULL
95-kDa	NULL
Sp1	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
are	NULL
different	NULL
.	NULL

The	NULL
CD14	NULL
Sp1	NULL
binding	NULL
oligonucleotide	NULL
only	NULL
interacts	NULL
with	NULL
the	NULL
105-kDa	NULL
form	NULL
of	NULL
Sp1	NULL
.	NULL

The	NULL
higher	NULL
percentage	NULL
of	NULL
95-kDa	NULL
Spl	NULL
in	NULL
HeLa	NULL
cells	NULL
may	NULL
compete	NULL
out	NULL
the	NULL
105-kDa	NULL
Sp1	NULL
for	NULL
CD14	NULL
promoter	NULL
binding	NULL
and	NULL
thus	NULL
reduce	NULL
CD14	NULL
expression	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Although	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
any	NULL
other	NULL
factors	NULL
interacting	NULL
with	NULL
Sp1	NULL
by	NULL
in	NULL
vitro	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
it	NULL
is	NULL
still	NULL
possible	NULL
that	NULL
Sp1	NULL
interacts	NULL
with	NULL
other	NULL
specific	NULL
factors	NULL
in	NULL
vivo	NULL
;	NULL
for	NULL
ex-ample	NULL
,	NULL
RB	NULL
can	NULL
activate	NULL
the	NULL
c-fos	NULL
and	NULL
insulin-like	NULL
growth	NULL
factor	NULL
II	NULL
promoters	NULL
through	NULL
Sp1	NULL
sites	NULL
,	NULL
although	NULL
no	NULL
complexes	NULL
between	NULL
RB	NULL
and	NULL
Sp1	NULL
could	NULL
be	NULL
observed	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
(	NULL
Udvadia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Kim	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
-227	NULL
to	NULL
+80	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
appears	NULL
to	NULL
direct	NULL
tissue-specific	NULL
transcription	NULL
,	NULL
and	NULL
DNase	NULL
I	NULL
footprinting	NULL
experiments	NULL
reveal	NULL
four	NULL
regions	NULL
of	NULL
this	NULL
part	NULL
of	NULL
the	NULL
CD14	NULL
promoter	NULL
which	NULL
interact	NULL
with	NULL
nuclear	NULL
proteins	NULL
.	NULL

Besides	NULL
Sp1	NULL
,	NULL
other	NULL
factors	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
promoter	NULL
,	NULL
and	NULL
possibly	NULL
with	NULL
Sp1	NULL
,	NULL
could	NULL
be	NULL
important	NULL
for	NULL
tissue	NULL
specific	NULL
expression	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
did	NULL
not	NULL
directly	NULL
show	NULL
any	NULL
monocytic	NULL
specific	NULL
interactions	NULL
of	NULL
nuclear	NULL
proteins	NULL
with	NULL
the	NULL
CD14	NULL
promoter	NULL
in	NULL
this	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
although	NULL
ubiquitous	NULL
factors	NULL
might	NULL
interact	NULL
with	NULL
the	NULL
CD14	NULL
promoter	NULL
in	NULL
a	NULL
non-tissue	NULL
specific	NULL
manner	NULL
in	NULL
vitro	NULL
,	NULL
they	NULL
only	NULL
bind	NULL
to	NULL
CD14	NULL
promoter	NULL
in	NULL
vivo	NULL
in	NULL
CD14	NULL
positive	NULL
cells	NULL
;	NULL
an	NULL
example	NULL
in	NULL
monocytic	NULL
cells	NULL
is	NULL
the	NULL
interaction	NULL
of	NULL
Spl	NULL
with	NULL
the	NULL
myeloid	NULL
specific	NULL
gene	NULL
CD11b	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

This	NULL
possibility	NULL
can	NULL
be	NULL
confirmed	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
.	NULL

Alternatively	NULL
,	NULL
such	NULL
ubiquitous	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
Spl	NULL
,	NULL
may	NULL
be	NULL
altered	NULL
by	NULL
modifications	NULL
,	NULL
such	NULL
as	NULL
phosphorylation	NULL
,	NULL
to	NULL
contribute	NULL
to	NULL
differential	NULL
regulation	NULL
of	NULL
promoter	NULL
activity	NULL
.	NULL

Our	NULL
results	NULL
sug-	NULL
11434	NULL
gest	NULL
that	NULL
such	NULL
modification	NULL
of	NULL
Spl	NULL
may	NULL
indeed	NULL
contribute	NULL
to	NULL
the	NULL
monocytic	NULL
specificity	NULL
of	NULL
CD14	NULL
expression	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
H.	NULL
W.	NULL
Lioms	NULL
Ziegler-Hettbrock	NULL
for	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
Steve	NULL
Jackson	NULL
for	NULL
the	NULL
anti-Spl	NULL
antibody	NULL
,	NULL
Richard	NULL
Rickles	NULL
for	NULL
the	NULL
tissue	NULL
plasminogen	NULL
activator	NULL
promoter	NULL
DNA	NULL
,	NULL
Albert	NULL
Courey	NULL
and	NULL
Robert	NULL
Tjian	NULL
for	NULL
the	NULL
pPac§Sp1	NULL
expression	NULL
construct	NULL
,	NULL
and	NULL
Tim	NULL
Burn	NULL
,	NULL
Anne	NULL
Satterthwaite	NULL
,	NULL
Steven	NULL
Ackerman	NULL
for	NULL
many	NULL
helpful	NULL
discus-sions	NULL
.	NULL

REFERENCES	NULL
Ausabel	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Struhl	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
pp	NULL
.	NULL

4.7.1	NULL
,	NULL
Green	NULL
Publishing	NULL
Associates	NULL
and	NULL
Wiley	NULL
Interscience	NULL
,	NULL
New	NULL
York	NULL
Ball	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
Graziano	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Shen	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Fanger	NULL
,	NULL
M.	NULL
W.	NULL
(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
.	NULL

8	NULL
.	NULL

A	NULL
.	NULL

79	NULL
,	NULL
5974-5978	NULL
Borellini	NULL
,	NULL
F.	NULL
,	NULL
He	NULL
,	NULL
Y.	NULL
F.	NULL
,	NULL
Aquino	NULL
,	NULL
A.	NULL
,	NULL
Yu	NULL
,	NULL
G.	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
and	NULL
Glazer	NULL
,	NULL
R.	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
15850-15854	NULL
Chen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Okayama	NULL
,	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
Biotechniques	NULL
6	NULL
,	NULL
632-638	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Scheibe	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Zhang	NULL
,	NULL
D-E.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
8230-8239	NULL
Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
Courey	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
887-898	NULL
Darrow	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Rickles	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Pecorino	NULL
,	NULL
L.	NULL
T.	NULL
,	NULL
and	NULL
Strickland	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
5883-5893	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
85	NULL
,	NULL
79-87	NULL
Ghosh	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
(	NULL
suppl	NULL
.	NULL
)	NULL

2091	NULL
Goyert	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Ferrero	NULL
,	NULL
E.	NULL
,	NULL
Rettig	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Yenamandra	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Obata	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Le	NULL
Beau	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
239	NULL
,	NULL
497-500	NULL
Greenblatt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
1067-1070	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Ritz	NULL
,	NULL
J.	NULL
,	NULL
Nadler	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Schlossman	NULL
,	NULL
S.	NULL
F.	NULL
(	NULL
1981	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

68	NULL
,	NULL
932-941	NULL
Gumucio	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Rood	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Blanchard-McQuate	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Gray	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Saulino	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
1853-1863	NULL
Haziot	NULL
,	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
S.	NULL
,	NULL
Ferrero	NULL
,	NULL
E.	NULL
,	NULL
Low	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Silber	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Goyert	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

141	NULL
,	NULL
547-552	NULL
Hoey	NULL
,	NULL
T.	NULL
,	NULL
Weinzierl	NULL
,	NULL
R.	NULL
O.	NULL
,	NULL
Gill	NULL
,	NULL
G.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Dynlacht	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
29	NULL
,	NULL
247-260	NULL
Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
125-133	NULL
Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
MacDonald	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Lees-Miller	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
13	NULL
,	NULL
155-165	NULL
Jane	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Gumucio	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Cunningham	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3272-3281	NULL
Katai	NULL
,	NULL
H.	NULL
,	NULL
Terato	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Raghow	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
73-81	NULL
Kim	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Onwuta	NULL
,	NULL
U.	NULL
S.	NULL
,	NULL
Lee	NULL
,	NULL
Y.	NULL
L.	NULL
,	NULL
Li	NULL
,	NULL
R.	NULL
,	NULL
Botchan	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Robbins	NULL
,	NULL
P.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2455-2463	NULL
Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Celada	NULL
,	NULL
A.	NULL
,	NULL
van	NULL
Beveren	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Maki	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
113-124	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
227	NULL
,	NULL
680-685	NULL
Sp1	NULL
Directs	NULL
Monocytic	NULL
Specific	NULL
CD14	NULL
Promoter	NULL
Expression	NULL
Lauener	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Goyert	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Geha	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Vercelli	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20	NULL
,	NULL
2375-2381	NULL
Letovsky	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
2639-2653	NULL
Matsuura	NULL
,	NULL
K.	NULL
,	NULL
Ishida	NULL
,	NULL
T.	NULL
,	NULL
Setoguchi	NULL
,	NULL
M.	NULL
,	NULL
Higuchi	NULL
,	NULL
Y.	NULL
,	NULL
Akizuki	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
21787-21794	NULL
Morabito	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Yu	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Barnstable	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
9667-9672	NULL
Nordeen	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Biotechniques	NULL
6	NULL
,	NULL
454-458	NULL
Oberg	NULL
,	NULL
F.	NULL
,	NULL
Botling	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
3487-3495	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Burn	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

19	NULL
,	NULL
1038-1041	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Rosmarin	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
865-870	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Scheibe	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Zhang	NULL
,	NULL
D-E.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Galson	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
5014-5020	NULL
Pascal	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1646-1656	NULL
Pongubala	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Nagulapalli	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Atchison	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
368-378	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

16	NULL
,	NULL
402-408	NULL
Saffer	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
Annarella	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2189-2199	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
pp	NULL
.	NULL

18.62-18.63	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Sanger	NULL
,	NULL
F.	NULL
,	NULL
Nicklen	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Coulson	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1977	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

74	NULL
,	NULL
5463-5467	NULL
Schaufele	NULL
,	NULL
F.	NULL
,	NULL
West	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
and	NULL
Reudelhuber	NULL
,	NULL
T.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
17189-17196	NULL
Simmons	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Tan	NULL
,	NULL
S.	NULL
,	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Nicholson-Weller	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Seed	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
284-289	NULL
Skalnik	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Strauss	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
16736-16744	NULL
Smale	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
103-113	NULL
Spanopoulou	NULL
,	NULL
E.	NULL
,	NULL
Giguere	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2216-2228	NULL
Udvadia	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Rogers	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Higgins	NULL
,	NULL
P.	NULL
D.	NULL
R.	NULL
,	NULL
Murata	NULL
,	NULL
Y.	NULL
,	NULL
Martin	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Hum-phrey	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Horowitz	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
3265-3269	NULL
Wagner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
395-399	NULL
Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
Heidecker	NULL
,	NULL
G.	NULL
,	NULL
Huleihel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
2247-2250	NULL
Weston	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
3043-3049	NULL
Williams	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
670-682	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Ramos	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Mathison	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1431-1433	NULL
Yu	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Motamed	NULL
,	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
,	NULL
Bailey	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Shen	NULL
,	NULL
C.	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
8907-8915	NULL
Zaret	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Liu	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
and	NULL
DiPersio	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
5469-5473	NULL
Zhang	NULL
,	NULL
D-E.	NULL
,	NULL
Hoyt	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Papaconstantinou	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
3382-3391	NULL
Zhang	NULL
,	NULL
D-E.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
H-M.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
373-381	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Eur	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

49	NULL
,	NULL
1-12	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Thiel	NULL
,	NULL
E.	NULL
,	NULL
Futterer	NULL
,	NULL
A.	NULL
,	NULL
Herzog	NULL
,	NULL
V.	NULL
,	NULL
Wirtz	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Riethmuller	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
41	NULL
,	NULL
456-461	NULL

